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Addiction to opiates is a complex public health issue affecting thousands of Canadians.  
Methadone Maintenance Treatment (MMT) is considered the gold standard in Canada, 
and the world, for treating opiate dependence.  In the past, Canadian research into opiate 
addiction and the effectiveness of MMT has mostly focused on larger cities:  Toronto, 
Montreal, and Vancouver.  This community based research study employed a mixed 
method approach to gain understanding of the experiences and satisfaction with MMT 
and other health services available to opiate users in Belleville, Ontario (population 
48,000).  Surveys (N = 53), focus groups, participant-observation methods and key 
informant interviews were used to gather data.  The results provide an overall picture of 
the quality of life for opiate users and MMT clients, the quality of care clients receive, 
and the perceptions of community members regarding MMT.  Challenges related to 
smaller locales are identified along with recommendations for improving MMT health 
services. 
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Elizabeth is a petite woman in her mid fifties; frail and delicate. You would not know her 
secret simply by looking at her but Elizabeth is addicted to prescription opiates.  Her 
downward spiral began innocently enough with a legitimate OxyContin prescription from 
her doctor for pain some two years earlier.  Elizabeth never expected to find herself 
walking into the Belleville Freedom Support Center to complete a survey about opiate 
addiction and local methadone maintenance treatment services.  As with any person who 
inquired about the survey, Elizabeth was briefly interviewed to verify her qualification 
for the study.  “I can’t get the pills from my doctor anymore.  If I don’t have them, I get 
really sick.  I’m so embarrassed,” she says as she wipes away tears.  I reach across the 
table to hold her hand and ask if she has ever considered methadone.  Elizabeth does not 
know a lot about methadone but is adamant that she will not risk being seen entering the 
methadone clinic situated on the main street.  I tell her about the other clinic which is 
less visible to the public.  She did not know there was a second clinic in town and seems 
very interested in checking it out.  I introduce her to the street nurse for further support 
and information.  Elizabeth qualifies for the study.  Unfortunately, her story is not 
unique. 
 
Methadone maintenance treatment (MMT) is a health service that is widely 
available across the province of Ontario.  MMT services exist to assist individuals who 
are opiate dependant.  This thesis explores the experiences and satisfaction with 
methadone maintenance treatment (MMT) along with other health services in the context 
of a small Ontario city. The research for this study was conducted in Belleville, Ontario; 
population approximately 48,000 (Statistics Canada, 2007a).  Belleville, Ontario is 
situated along the 401 corridor between Toronto and Ottawa.  Set along Lake Ontario‟s 
scenic Bay of Quinte, it is also the gateway to Ontario‟s Prince Edward County; famous 
for its many vineyards, artists, and Sandbanks Provincial Park.  Belleville serves as the 
main service hub for many outlying rural towns and villages.  Geographical factors limit 
most forms of affordable public transit to the immediate city limits making access to 
some essential services challenging for persons who do not own a vehicle or who cannot 
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drive.  Belleville falls within the region of Hastings and Prince Edward Counties (HPEC).   
HPEC is a vast area covering approximately 155,970 square kilometres (Statistics 
Canada, 2007b).  Many rural towns and villages make up HPEC.   These rural, 
sometimes remote, settings would not likely be associated with substance abuse 
problems.  However, the town of Bancroft, population 3,800, (Statistics Canada, 2007b) 
recently opened its first needle exchange program (NEP) site with the help of the HPEC 
Health Unit (Key Informant Interview, 2011).   
Addiction to opiates can be so all-consuming that some who become dependent 
are never again drug free.  Attempts to address opiate dependence are supported through 
treatment programs such as MMT which has been described as a means of managing 
dependence rather than a cure for addiction (Ontario Ministry of Health and Long-Term 
Care (MOHLTC), 2007).  Through proper control and prescription by a physician, daily 
doses of oral methadone can prevent cravings for heroin, and other opiates, and limit 
withdrawal symptoms (MOHLTC, 2007).  MMT services can be offered in a variety of 
settings in conjunction with other health services.  Methadone clinics cater specifically to 
persons with opiate dependency.  Based on medical assessments, physicians who are 
licensed to prescribe methadone for opiate dependency provide MMT services to their 
patients (College of Physicians and Surgeons of Ontario (CPSO), 2011). 
At the time of this study (2010), there were two methadone clinics in Belleville, 
Ontario. These clinics are for-profit enterprises, operated as a part of franchises of clinics 
throughout the province.  In addition to the two methadone clinics, several pharmacies in 
the region (Hastings and Prince Edward Counties) dispense prescribed methadone 
(supervised) to patients receiving MMT.  The number of individuals in HPEC who were 
3 
 
receiving methadone for opiate dependence was estimated to be between 300 and 400 
people at the time this research was conducted (Key Informant Interview, 2011).    
In order to appreciate the health benefits associated with MMT services for both 
individuals and communities, it is important to first understand opiates, opiate addiction, 
the challenges and costs related to opiate addiction and the role MMT services play in 
addressing these issues.  The following provides background information on the same 
and provides some context for these issues as they exist in smaller locales versus larger 
urban centres.  
Background 
What are opiates? 
 
Opiates are drugs which originate from the poppy plant.  Some opiates, such as 
heroin, are subjected to chemical change.  Those which remain chemically unaltered 
include opium, morphine, and codeine.  In addition to these plant-derived opiates are 
other commonly prescribed morphine-like drugs including methadone, Demerol, 
Percocet, and OxyContin to name a few.  These drugs are developed in a laboratory and 
are not derived from the poppy plant in any way.  Altogether, this family of 
pharmaceuticals is referred to as opioids.  Opioids, including methadone, have long been 
used by the medical community as a means to effectively manage acute and chronic pain 
due to physical trauma (Center for Addiction and Mental Health (CAMH), 2008).   
Opiates, such as heroin, produce a sense of euphoria in the user.  The effect is 
short-lived, resulting in the need for several doses of the drug over 24 hours to maintain 
the desired „high‟ and avoid illness associated with withdrawal.  Long-time users may 
suffer severe withdrawal symptoms (dope sickness) when there is too much time between 
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fixes, or doses, of an opiate.  Prolonged usage of opiates may result in increased tolerance 
and addiction, whereby the user requires the drug on a regular basis in order to function 
somewhat normally and avoid withdrawal symptoms (CAMH, 2008).    
What is Methadone?  What is MMT?   
 
 Methadone was first discovered in Germany in the 1940s and has been widely 
used for pain management since World War II.  In 1963 the world‟s first MMT program 
was established in Vancouver, B.C., based on research conducted in the 1950‟s by Robert 
Halliday.  Similar research conducted in the United States at that time concluded that 
methadone not only allowed persons addicted to morphine to withdraw with few side 
effects, but also their overall quality of life improved.  Most important was the realization 
that individuals no longer craved morphine while receiving methadone (MOHLTC, 
2007).   
Methadone is a long lasting opiate with few side effects.  It acts on specific 
receptors in the brain to block pain resulting from physical trauma without producing the 
„high‟ or sense of euphoria associated with usage of other opiates, such as heroin or 
morphine (CAMH, 2008).   
MMT has been considered the gold standard for treating opiate addiction worldwide 
since the 1960‟s (MOHLTC, 2007).  However, this effective replacement treatment 
strategy does not work for everyone. Some people (10 – 20%) do not respond well to 
MMT (Canadian Institutes of Health Research (CIHR), 2005).  Relapse into addiction is 
common; often characterized by an inability of some addicts to adhere to replacement 
therapies.  The World Health Organization (WHO) suggests that fewer than 10% of the 
estimated 16 million illicit opiate users, worldwide, are receiving substitution therapy.  In 
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countries where substitution strategies are available, 40% to 50% of opiate addicts 
receive some sort of replacement therapy (WHO, 2008). 
What is Harm Reduction?  How does MMT fit with Harm Reduction? 
 
In the context of drug addiction, harm reduction represents a philosophy of 
improving the quality of life for individuals and communities through the implementation 
of supports ranging from controlled use of substances to abstinence (Pauly, Goldstone, 
McCall, Gold, & Payne, 2007).  To date, harm reduction practices have been mostly 
focused on street outreach programs (street nurses) and inner city clinics.  A harm 
reduction approach addressing addiction to illicit drugs, including opiates, employs 
strategies such as:  Heroin Assisted Treatment (HAT), the establishment of supervised 
injection sites/facilities (SIF), Needle Exchange Programs (NEP), Methadone 
Maintenance Treatment (MMT) programs, educational programs to provide knowledge 
on safer injection practices, the provision of safe crack kits to addicts, and political 
reform on drug policies (Pauly et al., 2007).   
MMT is a replacement therapy strategy whereby patients replace their daily 
requirement for opiates with a prescribed oral dosage of methadone.  In order for MMT 
to be effective, programs must provide more than just the methadone (CPSO, 2011).  
According to the CPSO (2011) MMT programs should offer patients a multitude of 
services through a collaborative approach by a multidisciplinary health team.  
Specifically, Best Practices would include a patient‟s access to physicians, nurses, social 
workers, mental health workers, case managers, peer support, and pharmacists (CPSO, 
2011, p. 60).   Of these supports, counselling is identified as a key determining factor in 
the retention and effectiveness of MMT and should be provided even in the absence of 
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some/all of the other supports mentioned (CPSO, 2011).  MMT has been shown to have a 
positive impact on individuals and communities by:  1) reducing the transmission of 
blood borne diseases, 2) improving the overall health of patients, 3) reducing crime rates, 
and most importantly, 4) reducing morbidity and mortality associated with opiate 
addiction (CPSO, 2011). 
Delivery of MMT Services in Ontario 
 
The system for delivering overall health care in Ontario has recently undergone 
major restructuring.  Currently, the province of Ontario is divided into geographical 
regions referred to as Local Health Integration Networks or LHINs.  The provincial 
information and referral service known as the Drug and Alcohol Registry of Treatment 
(DART) is funded by Ontario‟s Ministry of Health and Long Term Care (MOHLTC).  In 
2007, Ontario‟s MOHLTC suggested that approximately 16,400 people in Ontario were 
receiving MMT for opiate addiction (MOHLTC, 2007).  Each LHIN reported on the 
number of persons who were formally referred to MMT programs by DART between 
January 1, 2006 and December 31, 2006.  For example, Hastings and Prince Edward 
Counties are part of the South East LHIN where 9 people were referred for methadone-
related services by DART during this time period (MOHLTC, 2007). 
The distribution of methadone, a controlled substance, is regulated at the federal 
level.  Specifically, the drug is regulated under the Controlled Drugs and Substances Act 
(CDSA) and the Narcotic Control Regulations (MOHLTC, 2007).  In order for physicians 
to legally prescribe methadone, they must receive an exemption from Canadian Law; 
Section 56 of the Act by Health Canada (MOHLTC, 2007).  In 2006, Health Canada 
granted Ontario physicians and pharmacists an exemption from Canadian law which 
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allowed them to prescribe and dispense methadone in methadone clinics and pharmacies 
to treat opiate dependence.  This exemption, initially granted on a pilot basis, continues to 
be granted from Health Canada.   Although this process is regulated by the federal 
government, it is monitored in Ontario by the College of Physicians and Surgeons of 
Ontario (CPSO).  Ontario physicians who prescribe methadone as part of a MMT 
program cannot do so without completing special requirements specific to the use of 
methadone for the treatment of addiction versus pain management (CPSO, 2011).  MMT 
may be delivered in a variety of health settings.  A number of MMT physicians choose to 
quietly operate out of their regular general practice, some choose to work for one of the 
„for profit‟ chains of clinics that offer MMT throughout the province, while others may 
choose to offer their services through „not for profit‟ out-reach centres, hospitals, 
residential addiction treatment facilities, or Community Health Centers (CHC) (CPSO, 
2011).  Regardless of the practice setting, MMT physicians must meet the following 
criteria in order to be granted a methadone exemption: “1)  Hold a certificate of  
registration in Ontario, 2) Be in good standing with the CPSO, 3) Complete an 
application form and agree to practice in accordance with the CPSO‟s expectation 
document, 4) Complete the Opioid Dependence Treatment Core Course through CAMH, 
and 5) Complete two days of clinical training with a MMT physician approved by the 
CPSO” (CPSO, 2011. p. 24).  Physicians meeting these requirements are initially 
exempted for one year with successive exemptions granted every three years (CPSO, 




Delivery of MMT and NEPs in Belleville, Ontario 
 
Although statistical information regarding the total number of persons currently 
accessing the two methadone clinics in Belleville, Ontario, for MMT is not available, 
estimates range between 300 and 400 people (Key Informant Interview, 2011).  Both 
clinics are for-profit agencies where clients can be seen by a physician who has met the 
CPSO requirements necessary to assess opiate users and prescribe methadone to treat 
opiate dependence.  Clients who are accepted into the local MMT programs also receive 
care from the nursing staff that, among other services, dispense methadone and monitor a 
patient‟s daily consumption of their prescribed dose.  Patients may also receive their daily 
methadone at one of several pharmacies who have pharmacists on staff able to dispense 
the drug and monitor consumption by patients who do not receive carries.   
The term, „carries‟, refers to a patients‟ ability to take multiple days worth of their 
prescribed dose(s) of methadone home with them.  Methadone is a powerful synthetic 
opiate.  Ontario has a history of methadone usage by non-MMT clients which has 
resulted in serious harms and fatalities.  As such, methadone is strictly regulated.  Once 
stabilized, some patients may qualify for the option to receive carries.  Specific standards 
and guidelines exist to guide physicians with ascertaining a patient‟s readiness for carries 
(CPSO, 2011).  The following criteria outlines some of the considerations for providing 
patients with the option to have carries; (1) after two months of MMT, patients may be 
considered for carries if they are deemed mentally and physically stable and have 
demonstrated no other substance use one week prior to receiving their carries.  This 
means that patients are identified as low risk for misuse of their carries (diversion to the 
streets, overdose, relapse, etc.) and can be trusted to take the dosage(s) as prescribed; (2) 
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patients must provide evidence that they can safely store their carries at home.  This 
involves patients showing the clinicians the locked box they will use to store their 
methadone at home; (3) the number of carries prescribed may increase by one every two 
to four weeks based on the physician‟s assessment and adherence to carry protocols by 
the patient (CPSO, 2011).  The option for carries alleviates the inconvenience of daily 
trips to the methadone clinic for patients.  However, this practice is somewhat 
controversial as some methadone is sold illegally on the street.  As such, strict monitoring 
and prescribing policies regarding access to carries are outlined by the CPSO (2011) to 
help physicians curb the diversion of methadone to the streets.  The CPSO standards and 
guidelines for prescribing carries apply to all physicians who prescribe and dispense 
methadone to opiate dependent patients in the province of Ontario (CPSO, 2011). 
Needle Exchange Programs (NEPs) are available in communities throughout 
Hastings and Prince Edward Counties.  In Belleville, NEPs are offered at designated 
pharmacies and agencies affiliated with the local health unit.  One critical site is located 
in Belleville‟s downtown core at the Belleville Freedom Support Center (BFSC).  The 
BFSC is a drop-in center run by the local Mental Health Support Network (MHSN).  The 
community based research for this thesis was conducted largely through the BFSC with 
support and approval from the local MHSC and the HPEC Injection Drug Use Harm 
Reduction Task Force (HRTF).  The BFSC offers more than just clean needles and works 
(drug paraphernalia) to injection drug users.  It offers a space where opiate users are able 
to connect and interact with frontline health workers.  Some services they may receive 
include: 1) health care and support from the local street nurse, 2) support and information 
from a health unit staff nurse who operates the bi-weekly sex health clinic, 3) peer-
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counselling and support in a non-judgmental environment, and 4) information about 
health services, such as MMT, available in the community.  
Opiate Addiction – The Scope of the Problem   
 
In 2008, the WHO (2008), reported that an estimated 16 million people, 
worldwide, were using illicit opiates.  Information compiled from a longitudinal 
OPICAN study states that an estimated 125,000 Canadians were injection drug users 
(IDUs); with the majority of these injecting cocaine and/or heroin (Fischer, Rehm, Patra, 
and Firestone-Cruz, 2006).  Data regarding trends among opiate users was also gathered.  
The research indicated the occurrence of significant, ongoing changes in the illicit use of 
opiates in Canada since the 1990s.  Although Vancouver and Montreal remained fairly 
constant with large numbers of heroin users, prescription opiates were identified as fast 
becoming the opiate of choice for users in other areas of the country (Fischer et al., 
2006a).  
For those addicted to opiates, the physical need is so strong that addicts must have 
the drug to avoid sickness related to withdrawal.  Many have stated they will do anything 
to get it, including committing criminal acts such as theft and prostitution (O‟Brien, 
2008).  Risky behaviours, such as unprotected sex and unsafe injection practices, have 
been associated with increased harm to both drug users and communities.  Unprotected 
sex may potentially result in the spread of sexually transmitted infections (STIs).  Unsafe 
injection practices such as sharing needles, using un-sterilized needles and other 
associated injection paraphernalia, and improper disposal of used syringes have the 
potential to negatively impact IDUs and threaten to expose the general public to serious 
health risks (Registered Nurses Association of Ontario (RNAO), 2009).   
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In 2009, the RNAO reported that an estimated 46% of the 30,000 IDUs in 
Toronto, Ontario, share needles and partake in other unsafe injection practices.  Common 
infectious diseases associated with addicts who are IDUs include HIV and Hepatitis C 
Virus (HCV) (RNAO, 2009).  Illicit drug use has been clearly identified as a key risk 
factor for HCV infections (Fischer, Kalousek, Rehm, Powis et al., 2006).  In 2006, 
approximately 300,000 Canadians were infected with HCV.  Future estimates include 
6,000 new cases per year. Of these new cases, 75% will be directly related to illicit drug 
use (Fischer et al., 2006b).  The annual cost associated with HCV-related illness in 
Canada was estimated to be $500 million dollars in 2006 with potentially substantial 
increases forecasted over the next 20 years (Fischer et al., 2006b).   
Social determinants of health include, but are not limited to:  1) poverty, 2) 
economic inequality, 3) social status, 4) education and early life care, 5) social exclusion, 
6) social support, 7) employment/job security, and 8) food security (Canadian Nurses 
Association (CNA), 2005).  All of these factors are deemed instrumental in determining 
the overall health/well-being of individuals and, as such, must be considered while 
exploring the effectiveness of, and satisfaction with, current health services (including 
MMT) available to opiate users (RNAO, 2009).  Many individuals who enter MMT 
programs in Ontario struggle with securing the basic necessities of life (RNAO, 2009).  
Education levels tend to be lower than the average among MMT clients which results in 
the reduced ability to secure employment that provides an adequate income.  Many MMT 
clients rely on social assistance and poverty is common among illicit opiate users and 
MMT clients.  Specifically, food security, and suitable housing are among the challenges 
MMT clients on low/fixed incomes face.  In many instances, MMT clients are homeless 
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or close to homeless, and must rely on social supports to supplement groceries (RNAO, 
2009).   
Stigma 
 
Goffman (1963) identifies stigma as the negative evaluation by others toward an 
individual, or group of individuals, who deviate in some way from what is considered 
normal; including their appearance, social/racial associations, or behaviour.  Stigma is 
often associated with drug addiction and is another key issue facing individuals who are 
opiate dependent (Neale, Nettleton, & Pickering, 2011).   Neale, Nettleton, and Pickering 
(2011) cite a study conducted in the 1908s by Biernacki (1986), who studied heroin users 
in the United States that had stopped using opiates without any medical assistance.  
Biernacki was trying to determine the impact of social stigma and an addict‟s sense of 
self/identity on their ability to stop using drugs and improve their lives.  Biernacki 
discovered that the existence of social stigmas toward heroin addicts translated into 
insurmountable barriers for individuals who were trying to quit using drugs.  Not only 
does stigma exist for drug users (including opiate users), but there is also stigma 
associated with individuals who use MMT (Anstice, Strike, & Brands, 2009).  It is 
therefore, imperative that frontline health workers (doctors, nurses, pharmacists) who 
interact with MMT clients recognize the potential negative impact of any biases they may 
have toward drug users and MMT clients (Anstice, Strike, & Brands, 2009). 
Why should we care? 
 
Why should we care about opiate addiction and the effectiveness of treatment 
strategies such as MMT in Canada and, more importantly, our own communities?  The 
answer is multi-faceted.  Although opioids, such as heroin and OxyContin, can be snorted 
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and smoked, a large number of users inject drugs.  Many street addicts share needles, or 
use dirty needles.  These practices increase the risk and incidence of blood born diseases 
such as HCV and HIV (WHO, 2008).  Improperly discarded needles used by infected 
opiate users also expose the general public to risk of disease, making addiction a 
community problem.   
Studies conducted in the 1990‟s indicated a direct correlation between extremely 
high rates of HIV and IDUs; especially in communities lacking sufficient and effective 
prevention efforts or harm reduction strategies (Millson, Challacombe, Villeneuve, Strike 
et al., 2007).  In 2006, the reported rate of overdose in Canada was approximately 500 – 
1000 events per year (Fischer, Popova, Rehm, & Ivsins, 2006).  Even more shocking was 
the rate of one death per day in the mid-1990s in Vancouver, BC.  Furthermore, the 
annual mortality rate associated with IDU during this time period was 1-2% for addicts 
(Fischer et al., 2006c). 
Apart from human suffering associated with opiate use, the related social costs are 
staggering.  They include: (1) the arrest and incarcerations of addicts, (2) health care to 
treat illness related to addiction, and (3) social assistance to support users unable to work 
and support themselves through legal means.  No current dollar values associated with 
societal costs was located.  However, the RNAO (2009) reported that the yearly social 
costs associated with untreated opiate dependence in Canada in 1999 were an estimated 
5.3 million dollars.  Finally, in 2006 the estimated yearly personal and societal cost 








As previously stated, full MMT programs that adhere to Best Practices remain an 
accepted, effective „harm reduction‟ approach to the management of opiate addiction in 
Canada, and abroad (WHO, 2008).  For decades, studies have been conducted on the 
effectiveness of MMT (MOHLTC, 2006).  With the majority of Canadian research 
focused on treatment services in major cities, there is clearly a lack of research targeting 
rural/urban areas where the incidence of prescription opioid dependency appears to be 
highest (Fischer, Gittins, & Rehm, 2008).  Considering Canada‟s unique geography and 
the number of small cities and towns inside each province, studies focused on MMT 
services available to users in smaller cities and towns is warranted.  Adequate access to 
MMT has been identified as a significant issue for individuals who live in rural or remote 
communities (MOHLTC, 2007).  Furthermore, the current shift in opiate use and 
dependence from heroin to prescription opiates makes studies focused on smaller locales 
even more important.  The shift to dependence on prescription opiates means that these 
drugs are more widely available as geographical considerations (transportation of 
substances) is less of a concern.  The size and location of a community no longer limits 
the illegal supply and accessibility of opiates (Fischer, Gittins, & Rehm, 2008).   
Rural needs, services and attitudes vary significantly from those in larger centres 
and directly impact care and support available to opiate addicts in smaller locales.  
Access to treatment is an issue for opiate users living in rural communities.  For example, 
travel to methadone clinics is an issue, especially for those receiving no financial 
assistance and who are among the poorest in communities.  Many MMT clients do not 
reside in areas where public transit is available. Thus, the cost associated with travel in 
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order to access clinics is an issue (Taylor Field Notes, 2010).  Costs may be incurred 
directly by clients or the health care system if clients are relying on social assistance to 
pay for transportation (Key Informant Interview, 2011).  For individuals who may receive 
financial assistance from the government, access to MMT clinics may still depend on the 
distance they are required to travel to the nearest facility. The standards of care may 
differ in rural clinics versus city clinics due to isolation and perhaps lack of supports 
(Taylor Field Notes, 2010).   Finally, it may be harder to protect anonymity in small 
town/rural clinics as individuals may have a greater chance of being recognized by 
someone they know as they enter a methadone clinic (Taylor Field Notes, 2010).  
Individuals may experience negative consequences/stigma around being a MMT client 
and their non-medical drug use. 
The following chapter reviews current literature regarding Best Practices for 
MMT in Ontario, factors related to effective MMT programs, and current trends in opiate 
use and treatment strategies.  The research methods used in this community based 
research study will be presented along with results from the analysis of the data collected.   
Results from the following study will contribute to the support of current MMT practices 
meeting the needs of MMT clients accessing care in Belleville, Ontario, as well as 
identify areas for improvement.  Research findings may be useful to local health 
professionals, for example, doctors, nurses and pharmacists, and community outreach 
workers (needle exchange programs, street nurses).  Most important is the potential for a 
positive impact on the lives of those suffering from opiate dependence.  Acquiring a 
better understanding of the effectiveness of current services available in a community 
provides an opportunity for caregivers and service providers to identify problems and 
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make necessary improvements.  Improved services and care for individuals may increase 
their chances at a more normal life and provide them with better health care overall.  
Finally, a better understanding of MMT as a necessary health care service by health 
providers and the general public may reduce the stigma associated with opiate 
























The following literature review presents information on existing treatment options 
for opiate dependence in Canada and abroad, trends regarding opiate use in Canada and 
North America, and the current paradigm shift in opiate use and addiction.  Articles that 
focused on harm reduction strategies such as Methadone Maintenance Treatment (MMT) 
and Heroin Assisted Treatment (HAT), relapse, and alternative approaches to treatment 
for opiate addiction were reviewed.  Searches for relevant data were conducted using the 
University of Ontario Institute of Technology (UOIT) library databases and online 
inquiries.  This data was limited to peer-reviewed sources of information with a 
preference for those published no earlier than 2005.  It is interesting to note that the 
majority of documentation from Health Canada was dated 2002 or older.   
Treatment Strategies Currently Available for Opiate Dependence 
 
The Harm Reduction Approach 
 
As previously stated in Chapter one, harm reduction strategies have been shown 
to improve the quality of life for individuals and communities (Pauly, Goldstone, McCall, 
Gold, & Payne, 2007).  MMT has been described as the gold standard for treatment of 
opiate addiction (WHO, 2008) and is one of several harm reduction strategies currently 
available to address the problem.  Heroin Assisted Treatment (HAT), supervised injection 
sites/facilities (SIF), and Needle Exchange Programs (NEP) are examples of additional 
harm reduction approaches that may be available, to some degree, in cities and towns 




HAT and SIF 
 
Heroin Assisted Treatment (HAT) involves the use of medically prescribed heroin 
for addicts who do not respond favourably to traditional treatments such as MMT.  First 
used in Switzerland in the mid 1990s as part of research programs to address addiction 
problems, this controversial treatment was shown to be highly effective in reducing illicit 
drug use in public spaces and associated harms such as poor health and elevated crime 
rates.  Over the course of time, positive public opinion in Switzerland regarding HAT has 
led to implementation of these programs as part of standardized treatment for heroin 
addiction that is now policy (Firestone-Cruz, Patra, Fischer, Rehm & Kalousek, 2007). 
Canada has yet to adopt a legal policy allowing HAT programs. However, in a 
progressive attempt to address opiate addiction, two randomized control trials (RCT) 
using HAT were established in 2005 in Montreal and Vancouver.  Originally designed to 
include five major US cities and two Canadian cities, the North American Opiate 
Medication Initiative (NAOMI) project was ultimately limited to include only Canada 
(Oviedo-Joekes, Nosyk, Marsh, Guh, Brissette, Gartry, Krausz, Anis & Schechter, 2009).  
Funded by the CIHR to the amount of $8.1 million dollars, the study aimed to evaluate 
the effectiveness of HAT in a North American context (Oviedo-Joekes et al., 2009).   
Current Canadian literature is limited to information regarding the NAOMI 
projects‟ study design and limitations.  Oviedo-Joekes et al. (2009) identify the main 
aims of the Canadian trials as: 1) the affect on retention in treatment at one year and 2) 
the affect on reduced crime and illicit drug use in the target population after 
randomization into groups receiving/not receiving DAM (prescription heroin).  The 
involvement of a double-blind component in the study set the NAOMI project apart from 
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European trials.  The successful recruitment of subjects was attributed to the involvement 
of street outreach workers who interacted with addicts on a regular basis.  Needless to 
say, any RCTs involving the use of illegal drugs in a marginalized population face unique 
challenges and are highly controversial.  Oviedo-Joekes et al. (2009) suggest that ethical, 
moral and political considerations highly influence the design of research studies 
involving vulnerable, stigmatized populations.  Upon evaluation of the design and 
implementation of the NAOMI study, the authors conclude that similar rigorous trials in 
the future are needed to provide quality information around alternative treatments for 
severe heroin addiction in Canada and around the world. 
Supervised Injection Facilities (SIFs) provide addicts with a safe, medically 
supervised, clean, space to inject their drug (Firestone-Cruz et al., 2007).  Similar to 
HAT, SIFs were first established in Switzerland, Netherlands, and Germany in the early 
1990s where the strategy was shown to reduce public disturbances and crime rates.  
Originally established illegally, public resistance abated over time, resulting in the 
acceptance of SIFs as a standard means of addiction treatment practice (Firestone-Cruz et 
al., 2007).  
This somewhat controversial harm reduction strategy has also been introduced to 
communities in Australia and Canada.  Vancouver, British Columbia, Canada established 
North America‟s first, and only, SIF (INSITE) in 2003.  In fact, the Vancouver mayoral 
election in 2003 was decided on the issue of establishing the facility. Despite the three-
year term outlined for the facility, INSITE continues to operate at full capacity.  Unlike 
European initiatives, politics surrounding the issue in Australia and Canada remains 
highly controversial.  Public and governmental support is mixed.  Interestingly, any 
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increases in public support for this strategy have been directly linked to perceptions that 
reduced crime rates and public disturbances are the result of established SIFs (Firestone-
Cruz et al., 2007).   
Kerr, Stoltz, Tyndall, Li, Zhang, Montaner, and Wood (2006) conducted a before 
and after study in response to high rates of HIV infections among IDUs worldwide and 
death rates attributed to overdose despite the availability of NEPs and MMT.  Public 
concern regarding the perception of increased drug use upon the establishment of SIFs 
was a main consideration.  The researchers recruited IDUs (N = 871) residing in 
Vancouver, BC.  Outcomes were measured based on the rates of relapse and abstinence 
by former/current IDUs.  The rates were analyzed prior to the opening of Vancouver‟s 
SIF.  This data was then compared to information gathered after the facility was 
established.  Results of the study indicated no increase in overall illicit drug use by IDUs 
with the establishment of a SIF despite some public perception to the contrary.  In fact, 
findings by Kerr et al. (2006) are consistent with other studies on the impact of SIFs.  The 
establishment of INSITE is shown to have improved public order and reduced needle 
sharing in Vancouver and relapses by former IDUs did not increase (Kerr et al., 2006). 
Stoltz, Wood, Small, Li, Tyndall, Zhang, Montaner, and Kerr (2007) conducted a 
comparative research study to determine if the establishment of INSITE in Vancouver, 
Canada had any effect on injecting practices; specifically needle sharing. The 
representative sample consisted of 760 IDUs accessing INSITE.  Subjects were randomly 
recruited; providing blood samples at baseline and a 6-month follow-up.  The researchers 
compared consistent and non-consistent use of the facility with injection practices as self-
reported by the research subjects.  Findings indicated improved injection and needle 
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disposal practices were associated with consistent use of INSITE.  Reduced rates of soft 
tissue infections were also identified.  This information is important as research 
conducted by Stoltz et al. (2006) identified soft tissue infections as being responsible for 
the majority of Emergency Room (ER) visits by IDUs in Vancouver, Canada.  As with 
similar studies, a reduction in public injection practices and overdose rates was observed 
(Bayoumi & Zaric, 2008). 
Firestone-Cruz et al. (2007) examined public opinion toward SIFs and HAT in 
Ontario, Canada.  Based on data collected from the 2003 Center for Addiction and 
Mental Health (CAMH) Monitor to gain understanding of public opinions on the 
establishment of HAT and SIF in Ontario, Canada, the authors argue that political 
decisions are based largely on public opinion of important matters; suggesting public 
opinion weights heavily on longevity of public programs – including SIFs and HAT.  The 
CAMH Monitor is an on-going cross-sectional telephone-based survey of Ontario adults 
conducted by CAMH targeting trends in alcohol, tobacco, other drug use and opinions 
regarding drug policies, mental health and gambling.  Subjects received four core 
statements regarding HAT and four regarding SIF to which they were to respond.  
Analysis of the data provided by the representative sample of Ontario adults showed 
support for both SIF and HAT for treating opiate addiction.  This was especially evident 
in respondents with post secondary education and those who viewed addicts as ill persons 
in need of health care.  Furthermore, the authors shared information on a recent survey of 
Canadians (N = 1,407) conducted by Decima Research where 56% were in favour of 
establishing SIFs in Canada.  In contrast, 45% believed punishment under the law for use 
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of illicit drugs was the best approach versus 52% who were opposed (Firestone-Cruz et 
al., 2007).   
The establishment of SIFs provides addicts with clean needles and materials 
necessary for safe injection.  This harm reduction strategy has been shown to reduce: the 
frequency of shared needles among addicts, the amount of discarded needles ending up in 
public areas, health risks associated with exposure to blood borne diseases, rates of HIV 
and HVC infections, and overall deaths from overdose (Bayoumi & Zaric, 2008).  SIFs 
provide addicts with increased levels of interaction with health care workers; encouraging 
access to physical and mental health services (Firestone-Cruz et al., 2007). 
NEPs 
 
Needle Exchange Programs (NEPs) are among the most prevalent harm reduction 
strategies available in Canada (Leshner, 2008).  This public health approach reduces 
blood-borne diseases (HIV/ AIDS, hepatitis) associated with unclean intravenous drug 
use practices, such as sharing needles and improper disposal of used needles.  The most 
effective NEPs are those providing services beyond needle exchange, including 
encouragement to enter treatment programs and/or seek additional care for physical and 
mental health issues (Leshner, 2008).   
MMT and Buprenorphine Replacement Therapy 
 
Methadone has been used to treat withdrawal symptoms related to heroin 
addiction, and other opiates, since the 1940s (MOHLTC, 2007).  Canadian researcher 
Robert Halliday established what some consider the world‟s first MMT program in 
Vancouver, B.C. in 1963.  Research in the United States was also conducted using 
methadone to treat heroin addiction in the 1960‟s.  This research revealed how using 
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methadone allowed addicts to gradually reduce their use of morphine (an opiate drug) to 
the point of total withdrawal; regaining normal, productive lives (MOHLTC, 2007).  
Although other substitute/maintenance treatment options are available, MMT remains the 
most successful treatment for addiction to heroin and other opiates across the globe 
(WHO, 2008). 
Of the estimated 80,000+ individuals using illicit opiates in Canada in 2006, 
30,000 resided in Ontario (CPSO, 2011).  According to Fischer et al (2006) the number 
of people, in Canada, receiving MMT for heroin addiction increased dramatically from 
approximately 5,000 spaces in mid 1990s to an estimated 25,000 spaces in 2006. This 
translated into 25% - 30% of opiate users in Canada receiving MMT for addiction in 
2006.  In 2007, the number of individuals in Ontario receiving MMT was approximately 
16, 400 (Silversides, 2009).  In 2009 this number rose by 70%; there were between 260 – 
280 physicians prescribing methadone for opiate dependence to an estimated 24,000 
individuals in the province of Ontario (Silversides, 2009).  MMT has been shown to 
reduce risk of HCV and HIV infections for addicts who adhere to treatment protocols and 
refrain from high-risk behaviours associated with injection drug use (Fischer et al., 
2006b). 
Kakko et al. (2007) conducted a RCT at a treatment facility in Sweden to compare 
MMT practices to other forms of treatment.  The study compared two randomly assigned 
similar groups (n=48 clients per group) of self-referred addicts attending a treatment 
facility. The research began as a double blind study (during first month) and continued 
single blind for the remaining ten months of the study. MMT programs were compared 
with use of a stepped strategy using buprenorphine, another opiate drug used in 
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replacement therapy. Results for the two groups were almost indistinguishable with 78% 
of subjects maintaining adherence at the end of the study.  Although researchers 
hypothesized the stepped strategy would not be equal to MMT programs, the study 
indicated buprenorphine is effective as an initial treatment, versus replacement for, 
traditional MMT practices.  However, in response to the study by Kakko et al., Brady 
(2007) made an important statement regarding the availability of methadone for patients 
and its short half-life as compared to buprenorphine.  According to Brady (2007), more 
research studies into the efficacy of buprenorphine replacement therapy for treating 
injection drug users (IDUs) and prescription opiate users are warranted as research on the 
latter is limited while becoming increasingly necessary considering usage trends 
previously discussed. 
The study by Nosyk et al. (2009) attempted to discern the effectiveness of MMT 
in British Columbia, Canada by accessing coded province-wide PharmaNet data 
regarding treatments provided to addicts between 1996 and 2007 (N = 32,656 treatment 
episodes).  The researchers constructed a proportional hazard gamma frailty model to 
determine effectiveness based on retention rates in MMT programs over six, 12, 24 
months, and one to six attempts at treatment.  Results indicated that addicts who 
repeatedly attempted to adhere to MMT practices were more successful over the long 
term with each successive attempt.  Of the clients who attempted treatment four to six 
times, their length of adherence increased by 85% - 90% as compared to initial and 
second attempts (Nosyk et al., 2009). 
In contrast, a study conducted at a treatment facility in New York, USA, used a 
combination of quantitative and qualitative research methods. In this case instruments 
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such as the Addiction Severity Index (ASI), Risk Behaviour Assessment (RBA), 
Opinions about Methadone (OAM) Scale, and focus groups were the vehicles used to 
examine attitudes towards MMT and the rate of relapse while addicts were enrolled in 
treatment.  Results showed a statistically significant reduction in adherence to MMT 
among individuals with negative attitudes toward methadone (Kayman, Goldstein, Deren 
& Rosenblum, 2006).  
In Canada, a RCT was conducted to examine the effects of a 6-month low-
threshold MMT program on injection-related HIV risk among opioid users in Kingston, 
Ontario and Toronto, Ontario (Millson, Challacombe, Villeneuve, Strike et al., 2007).  
The researchers studied MMT programs inside NEPs operating with a harm reduction 
focus.  Subjects for the study were users of opiates and recruited upon entry into low-
threshold MMT programs.  The study was conducted between 2000 and 2004.  Two 
hundred and three subjects were enrolled at baseline; 183 were interviewed at the 6 
month follow up.  Participants were mostly Caucasian males between the ages of 18-54.  
At 6-month follow up 138 of the original 183 subjects (92.7%) were still enrolled in their 
original MMT program.  Results indicated a statistically significant drop in injection drug 
use, sharing of needles and other injection equipment, indirect sharing, and the use of 
shooting galleries.  Risky behaviours associated with HIV were reduced regardless of 
whether clients achieved abstinence (Millson et al., 2007). 
There exists a solid body of literature examining traditional MMT for illicit opiate 
use in Canada and abroad.  Similar research studies focused on using MMT for the 
treatment of dependence on prescribed opiates are not as prevalent.  However, one recent 
retrospective cohort study was conducted in Washington State, USA, by Banta-Green, 
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Maynard, Koepsell, Wells, & Donovan (2009) to compare retention rates in MMT 
programs between users of prescribed opiates with heroin users.  The researchers were 
interested in determining whether prescription opiate users would derive the same benefit 
from traditional MMT programs as heroin users.  Data for the study was gleaned from an 
electronic information system (TARGET) compiled of data collected from the Addiction 
Severity Index (ASI) (Banta-Green et al., 2009).  Based on the analysis of the data, 
prescription opiate users were determined to be more apt to remain in MMT programs 
over 12 months as compared to heroin users (Banta-Green et al., 2009).  These results are 
encouraging considering that MMT programs are well established and widely available.  
Also, the results from this study are immediately useful to other countries, such as 
Canada, where prescription opiate use has been identified as a rising concern (Fischer, 
Gittins, & Rehm, 2009).     
Mendelson, Flower, Pletcher, and Galloway (2008) discussed the characteristics 
of patients identified with addiction to prescription opiates and the use of buprenorphine 
as a treatment strategy in the USA.  Unlike methadone, physicians can offer 
buprenorphine replacement care to patients from their offices.  This includes addressing 
any underlying emotional/psychological issues as well as opiate dependence.  Additional 
benefits associated with the use of buprenorphine included positive responses, both 
physical and cognitive, included the reduced likelihood of overdose as compared to 
methadone, and better adherence to treatment (Mendelson et al., 2008).  Further research 
into the length of treatment regimes using buprenorphine is warranted as little data 
currently exists.  The authors do not advocate replacing MMT with buprenorphine, 
however, the convenience and effectiveness of treating patients with prescription opioid 
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dependence in an office setting is very promising.  Until there is a system in place for the 
detection of patients at risk for opiate dependence, this may be one reasonable strategy 
for addressing the current problem (Mendelson et al., 2008).  
In Australia, a RCT was conducted in 2006 to compare MMT to buprenorphine 
for opioid dependence.  Ten years later, Gibson, Degenhardt, Mattick, Ali, White and 
O‟Brien (2008) conducted a longitudinal study on the subjects recruited in 2006 to 
determine any differences in mortality rates between the two groups.  The results of their 
study revealed no significant difference in mortality rates associated with either 
treatment.  In fact, older participants were identified as faring better with buprenorphine 
over MMT.  What did influence the overall outcomes was availability of treatment versus 
the drugs themselves.  Overall, this study supports similar findings regarding the 
effectiveness of buprenorphine as a long-term treatment option for opiate dependence in 
addition to traditional MMT (Gibson et al., 2008). 
Controversy Associated with Harm Reduction Approaches to Treatment 
 
Leshner (2008) has outlined some of the issues surrounding the debate over 
implementation of the aforementioned harm reduction strategies. Questions have been 
raised about whether or not the betterment of communities at large comes at the expense 
of the addicts.  Are health professionals supporting the continued use of and/or addiction 
to illicit drugs by advocating solutions other than abstinence?  Leshner (2008) has further 
identified the political controversy surrounding advocating the establishment of facilities 
(SIFs) where addicts are supervised by health professionals as they engage in illegal 
activity.  Consequently, policy-makers do not recognize research related to the topic 
resulting in a lack of support for such spaces because they do not want SIFs in their 
28 
 
communities.  Moreover, MMT and buprenorphine therapies are scrutinized as replacing 
one opiate addiction (heroin) with another (methadone /buprenorphine) versus abstinence 
by users.  These views exist even in the presence of extensive international research in 
support of MMT and other harm reduction strategies (Leshner, 2008). 
Nosyk and Anis (2009) cited more recent controversy regarding dispensing of 
methadone practices by pharmacists in Vancouver, Canada‟s, Downtown Eastside.  
Specifically, questions have been raised regarding incentives being offered to methadone 
patients by some pharmacists in Vancouver to entice customers and increase their 
business.  Other pharmacies offer supplemental mental health care which may/may not 
include a fee for service.  Nosyk and Anis (2009) discussed the positive and negative 
aspects associated with such practices, eventually coming to the conclusion that, 
regardless of the money being made, access to methadone is what is most important. 
The term harm reduction has been interpreted by some as meaning society should 
accept that addiction and its associated harmful behaviors (to self and others) are not 
curable and therefore should be supported by harm reduction approaches such as NEP, 
MMT, SIFs, and others.   In some instances the term becomes linked with legalization of 
illicit drugs.  This makes policy reform and implementation, and requests for research 
funding very difficult.  Leshner (2008) argued the term harm reduction should be 
changed to something more suitable in order to remove barriers to conducting research 
and the implementation of public health programs (Leshner, 2008). 
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Current Trends in Illicit Use of Opiates in North America 
 
In 2008, the Canadian Journal of Public Health released a report outlining the 
urgent need for increased research and policies regarding the growing trend of non-
prescription opioid abuse in Canada and North America (Fischer, Rehm, Goldman, & 
Popova, 2009).  These important recommendations were based on data gathered from 
(mostly) the United States of America (USA).  For example, reports indicated that the 
USA experienced an estimated increase of 300% in the abuse of prescription opioids 
among adults and youth between 1991 and 2001 (Fischer et al., 2009).  Furthermore, 
treatment for prescription opioid abuse in USA emergency rooms increased between 
three and six times between 1997 and 2002 with rates of overdose from the same 
doubling between 1999 and 2002 (Fischer et al., 2009).  One possible reason for this 
surge in the abuse of prescribed opiates may, in part, be due to the increased prescribing 
of potent opioids for pain management by physicians.  According to Fischer et al. (2009) 
the USA is now considered the world‟s leader in analgesic opioid prescription.   
 Canadian data on the same issues is sporadic at best.  However, Fischer et al. 
(2009) suggest similar trends associated with non-medical opiate abuse exist in Canada.  
Specifically, they cited the estimated 50% increase in consumption of prescription 
opioids in Canada between 2000 and 2004 as one indication.  Furthermore, in comparison 
to the USA, Canada ranks third in the world for prescribing opiates (Fischer et al., 2009).  
There is also cause for concern over recent data gathered from a study conducted in 2005 
on illicit drug use in five Canadian cities.  Results from the study suggested that the use 
of prescription opioids by addicts in some regions of the country has surpassed heroin.  
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Moreover, 80% of users receiving MMT in Toronto in 2002 identified themselves as 
using prescription opiates upon admission into a treatment program (Fischer et al., 2009). 
 In addition to the above, a recent article examined the epidemiology of the misuse 
of prescription opiates in North America.  The authors suggest this new trend in drug use 
began in the mid 1990s and has escalated to the point where street use of prescription 
substances is epidemic among users (Fischer, Gittins, & Rehm, 2008).  This information 
is based on longitudinal studies involving addicts enrolled in MMT as well as users who 
were not in treatment.  In both Canada and the USA, the study identified rural areas as 
having the largest increase in abuse of prescription opiates in recent years.  Interestingly, 
the assumption that heroin was being replaced with prescription opiates was proven 
wrong.  In fact, the majority of users in rural areas reported never having used or injected 
heroin prior to developing problems with prescription opiates (Fischer, Gittins, & Rehm, 
2008).   
As previously mentioned, the availability of prescribed opiates is seen as a major 
contributing factor in the misuse of these drugs.  Fischer, Gittins, and Rehm (2008) raised 
an important point when comparing illegal opiates to prescription opiates.  For example, 
illegal opiates are manufactured outside of North America, transported illegally and sold 
at street level using black market pathways.  Although they are not without scrutiny, 
strategies for the disruption of these actions (law enforcement efforts) have been in place 
for many years.  In contrast, addressing the influx of legal opiates for illegal use on the 
streets presents more of a challenge.  Fischer, Gittins, and Rehm (2008) identified 
multiple ways in which prescription opiates are able to reach users at the street level.  For 
example, patients may honestly, or dishonestly, present symptoms to physicians in order 
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to acquire opiate prescriptions, physicians and pharmacists may engage in illegal 
activities, patients may purposely seek more than one physician to fulfill prescriptions for 
the same condition (double-doctoring), and thefts targeting drug companies (internally 
and externally) may be committed (Fischer, Gittins, & Rehm, 2008).   
Intervention strategies introduced in the 1990s in parts of the USA were an 
attempt to control the amount of prescription opiates being misused.  These efforts have 
focused mainly on those who prescribe opiates through the establishment of prescription 
monitoring programs (PMPs).  However, questions have been raised about the 
effectiveness of these control efforts.  For example, prescribers are challenged to 
determine who is, and who is not, a legitimate candidate for prescription opiates.  In 
addition, prescribers have indicated that they may choose not to adequately prescribe 
medications for patients due to fear of scrutiny or investigation by authorities (Fischer, 
Gittins, & Rehm, 2008).  In many of the USA states where PMPs have been 
implemented, reports have indicated a substantial reduction in opiate prescriptions in 
comparison to states without established PMPs.  This may have serious implications for 
best practices treatment for pain management resulting in unintended harms to patients 
(Fischer, Gittins, & Rehm, 2008).    
Prescription opiates are not only misused at the street level.  Streltzer and 
Johansen (2006) have suggested that the increased use of prescribed opiates for patients 
suffering from chronic pain is a main contributor to the problem.  In their article, case 
studies involving real patients are presented as examples of how well-intentioned 
treatment regimes for legitimate health concerns can escalate to become a public health 
problem.  The physicians chronicled their experiences with patients who were prescribed 
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opioids for pain management and the resulting complications associated with their 
subsequent dependence on the medication.  In one case study, a patient fatally succumbed 
to her addiction to prescribed opiates.  Treatment strategies, including MMT and 
counselling, are outlined in the article as being paramount for patients who develop a 
dependence on prescribed opiate pain medication (Streltzer & Johansen, 2006).  
Knowledge Gaps and Future Trends 
 
In September, 2009, the Beckley Foundation Drug Policy Programme released a 
briefing paper comparing drug situations across six European countries, the USA, 
Canada, Australia and New Zealand.  Eight sets of indicators were used to guide the 
comparisons.  These included: 1) prevalence of drug use, 2) problem drug use, 3) drug-
related deaths, 4) rates of drug-related HIV and HCV, 5) drug-related arrests and 
punishments, 6) drug-related crimes, 7) costs of drug use, and 8) drug policy expenditures 
(Degenhardt, Hallam, & Bewley-Taylor, 2009).  Based on the results of the comparisons, 
the authors outlined discrepancies related to the ways in which individual countries 
measure drug use.  Arguments for the standardization of the process in the future were 
presented as the authors indicated the important role that each country‟s approach to the 
issue would have on the development of drug policy.  Collaboration between nations on 
this issue was presented as necessary in order to achieve a better overall understanding of 
changing trends in illicit drug use, and the harms associated with the problem on local 
and global scales.  These collaborative initiatives among nations were suggested as vital 
to the establishment of better evidence-based international drug policies in the future 
(Degenhardt, Hallam, & Bewley-Taylor, 2009).   
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While information currently exists regarding the number of persons accessing 
treatment for opioid addiction in North America, and around the world, there is clearly a 
lack of research and empirical data concerning the obvious paradigm shift in opiate use.  
For example, at present, there is no system in place to track and monitor the extent of 
prescription drug abuse in Canada.  Subsequently, this results in an additional lack of 
research and information regarding treatment strategies and options for the same.  As 
previously stated, the use of MMT for treating heroin addiction is well established.  
However, research regarding the effectiveness of MMT, over the long term, to treat 
prescription opiate dependence is lacking.  National surveys do not currently ask 
questions to address the issue of prescription drug abuse/dependence (Haydon, Rehm, 
Fischer, Monga, & Adlaf, 2005).  Haydon et al., (2005) recommend the inclusion of drug 
abuse categories and questions in national surveys, similar to those regarding illicit drug 
use as one way to address this knowledge gap.  In addition, research targeting smaller 
locales in North America may be warranted considering the current rise in prescription 
opiate use in these areas as formerly outlined in this document. 
In 2002, Mark Haden produced a document for the Canadian Journal of Public 
Health.  His article outlined and debated the eight national policies regarding illicit drug 
use in Canada which are still relevant today.  Although written almost a decade ago, 
Haden (2002) outlined recommendations for necessary changes in attitudes regarding the 
ineffective “war on drugs” approach to illicit drug use in Canada, calling instead for 
evidence-based drug control policies.  It is ironic that Canada continues to be stuck in a 
2002 mentality when it comes to dealing with this public health issue.  Many of the issues 
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Haden (2002) discusses, such as drug legalization, market regulation, allowing drugs to 
be prescribed, decriminalization, etc. remain unresolved.   
Research in North America, and the world, is beginning to address some of these 
concerns.  As a result, innovative approaches to the problem are beginning to emerge.  In 
addition to discussing well-established MMT approaches to managing opioid 
dependency, Abbott (2009) presented data involving supplemental psychological therapy 
for clients, referring to this form of treatment strategy as Community Reinforcement 
Approach (CRA).  Abbott (2009) reported on several USA studies conducted on the 
effectiveness of treating various types of dependency and associated elements (such as 
relapse) by combing CRA with medically prescribed drugs such as buprenorphine and 
naltrexone. One innovative study involved the use of CRA in combination with 
computer-assisted treatment (Abbott, 2009).  This study used a computerized treatment 
system in conjunction with a urinalysis monitoring device.  Clients received support and 
treatment via modalities such as videos and computer technology, and were required to 
complete certain educational tasks related to their condition.  Progress and urinalyses 
reports were received by therapists electronically.  Of the more than 80 clients registered 
in the program, 50% of clients showed a urinalysis free of opioids as compared to 35% 
enrolled in standard treatment and 56% who used therapy (Abbott, 2009).  This is a 
significant finding.  Not only was the CRA computer-assisted identified as an effective 
treatment for clients, it was more cost effective than the other treatments mentioned and 
showed equivalent retention rates (Abbott, 2009).  This option may be worth exploring as 
the face of opiate addiction continues to change.  Specifically, this treatment strategy may 
support patients who unintentionally develop dependence on prescription opiates and 
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have access to computer technology from home, as well as opiate users who live in 




Addiction to opiates continues to be a major public health issue in Canada.  
Disturbing new trends in opiate dependency in North America, and around the world, 
only add to existing political, medical, societal and personal challenges associated with 
the problem.  Fischer, Gittins and Rehm (2008) remind us that no intervention strategies 
are currently in place to stop the influx of prescription opiates into the world of illegal 
drug use.  Although MMT is the accepted gold standard nationally and globally for 
treating opiate addiction, literature reviewed for this document clearly indicates a need 
for increased research into the effectiveness of MMT for treating persons dependent on 
prescription opiates versus just heroin.   
It is clear that harm reduction approaches are supported worldwide as viable 
options for dealing with opiate addiction and associated harms affecting individuals and 
communities. British Columbia‟s perseverance in the 1990‟s to change mind-sets and 
attitudes toward dealing with issues related to drug addiction has opened the door for 
other Canadian cities to do the same.  Clinical trials, like the NAOMI Project, provide 
evidence of viable alternatives that might be modified to suit smaller centers. While 
strategies such as HAT and SIFs remain controversial and sparse, MMT remains an 
effective harm reduction approach to management of opiate addiction in Canada, and 
abroad.  Until such time as HAT and SIF options are more widely available, it would be 
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safe to assume that MMT will remain the standard form of treatment for heroin/opiate 
addiction in Canada.   
Current literature alerts us to the shift in opiate dependence from illicit street 
drugs (heroin) toward increased dependence on prescription opiates (OxyContin).   This 
shift in usage is compounded by geographical changes as smaller locales in North 
America experience marked increases in prescription opiate dependence by users who did 
not have an initial dependence on heroin.  The evidence is clear. Support through quality 
MMT and other harm reduction programs not only improves a quality of life and reduces 
co-morbidity for addicts, it improves the health of entire communities (Nosyk, et al., 
2009).  What is not clear is whether or not current MMT programs are able to meet the 
needs of shifting trends in the types of opiates being used and whether or not there are 
sufficient numbers of MMT programs to service the increase in the number of individuals 
requiring care and the geographical considerations that also must be addressed. 
The following research study has attempted to identify: 1) who is using opiates in 
a small Ontario city, 2) who is accessing MMT for their addiction, 3) whether or not the 
current services available are meeting the needs of individuals, and 4) what changes to 
existing MMT services might help improve access, retention, and success for individuals 
















The various methods used to conduct this research study were chosen in order to 
provide insight from all perspectives of the issues and to place the information gathered 
in the context of a small Ontario city. 
Research Aims and Objectives 
 
This study was designed to determine whether MMT, and other local health 
services, are meeting the needs of opiate users in Belleville, Ontario, Canada.  Belleville 
currently has two privately run, for-profit methadone clinics that provide MMT services 
to opiate users in Hastings and Prince Edward Counties.   Another option that may be 
considered for meeting the needs of opiate users in the community is a not-for-profit 
public MMT clinic.  In conversations with key informants, a common theme was 
identified.  Every person interviewed raised the question about having a not-for-profit 
clinic available as part of a public health clinic/centre that would also offer MMT 
programs for opiate users in the community.   
The effectiveness of health services available to the public can be measured in 
many ways.  Part of measuring the effectiveness of MMT involves considering users who 
would benefit from the services but, for any number of reasons, may not take advantage 
of them.  With this in mind, the research objectives for this study included: 
1. Placing current health services, including MMT programs, available to opiate 
users in Belleville, Ontario in the context of a rural community  
2. Enhancing the current understanding of the quality of life of individuals who 
might benefit from access to MMT. 
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3. Identifying the health care needs of opiate users who may/may not be 
accessing MMT services. 
4. Ascertaining whether opiate users accessing MMT are satisfied with the 
services provided. 
5. Suggesting ways to improve health services for opiate users based on what 
was learned from the investigation. 
Research Questions 
 
Quantitative and qualitative research techniques were used in an attempt to 
answer the following research questions: 
1. Among opiate users in Belleville, Ontario what is the satisfaction with current 
health services, including MMT, available to opiate users? 
2. What health services including MMT, do opiate users in Belleville, Ontario 
feel are most important and which services are they currently accessing?  
3. What are the experiences of persons currently accessing MMT in Belleville, 
Ontario?  
4. How do attitudes and opinions about MMT differ between opiate users 
accessing MMT and opiate users who do not? 
Research Methods:  A Community-Based Approach 
 
Supplementing quantitative results with qualitative information in health research 
allows for a human perspective on the issues being explored.  Qualitative methods used 
to gather research data may vary (Bowling & Ebrahim, 2007).  This community-based 
research study employed an ethnographic approach to the collection of qualitative data.  
Community-based research is defined as research that is conducted in community settings 
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and produces results which are meaningful to the community; a collaborative exercise 
between researchers and community stakeholders in the construction, execution, and 
distribution of the research and the subsequent findings (Center for Community Based 
Research (CCBR), 2011).  Community based research studies are used to benefit 
communities by facilitating social change and fairness (CCBR, 2011).  Ethnographic 
researchers engage in extensive fieldwork in their quest for knowledge regarding 
particular social groups as they exist in their natural surroundings (Creswell, 1998).   
Participant-observation is one qualitative method used by ethnographers.  Creswell 
(1998) describes this method as one in which the researcher becomes engrossed in the 
lives of a population being studied through in-depth interviews and/or detailed, lengthy 
observations of individuals in their natural environment over a period of time.   
This study employed all of the aforementioned community-based research 
principles.  Community stakeholders played an important, frontline roll in the execution 
of this study.  For example, in addition to ethical approval from the University of Ontario 
Institute of Technology (UOIT), support and approval from community stakeholders; the 
Hastings and Prince Edward Counties (HPEC) Injection Drug Users Harm Reduction 
Task Force (HRTF) (see Appendix A) and the local Mental Health Support Network 
(MHSN) was vital for data collection.  The HRTF, in conjunction with the local Health 
Unit, approved and supported the research at a quarterly meeting (April, 2009) based on 
the study‟s potential for having positive impact for opiate users and the community as a 
whole.  The MHSN required a formal copy of the research proposal which was reviewed 
by a committee responsible for overseeing the safety of individuals who access the local 
drop-in support center.  The researcher asked for permission to visit the centre on a 
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regular basis; at least two days per week between June 1, 2010 and July 31, 2010.  The 
MHSN approved the visitation request and also provided space to conduct the focus 
group sessions.  Without support from the MHSN, access to the target population may 
have proved more difficult.   
Initially, the sudden appearance by the researcher was met with some reservation 
by the regular members of the drop-in center.  However, approval by the members was 
quickly obtained due to the researcher‟s affiliation and relationship with the street nurse 
and peer councillors at the drop-in centre.  Accompanying the street nurse during rounds 
provided the researcher with an additional opportunity to associate with the target 
population.  Over the course of the data collection, personal contact between the 
researcher and individuals at the drop-in centre was extensive.  Trust and acceptance 
were gained over the course of the study as the researcher gradually became part of the 
scenery; eventually viewed as a trusted, familiar, non-judgmental person that the 
members and opiate users could talk to about their personal experiences over a cup of 
coffee, a game of chess, or a walk down the street.  The conversations were raw, honest, 
and, at times, disturbing.  Business at the centre carried on as usual once acceptance was 
gained and the researcher‟s presence did not appear to affect the regular happenings at the 
facility.  A detailed record of observations and field notes was generated over several 
months.  Although this inside opportunity provided the foundation for open and honest 
surveys, interviews, and focus groups, deception and/or misrepresentation did occur 
during these undertakings.  Regardless of this fact, the amount of time the researcher 




Quantitative data was collected using a survey tool which was made available and 
administered at the MHSN drop-in support centre, a centrally located space in the 
downtown core.  The facilitation of the survey was conducted by the researcher with 
assistance from the local street nurse who was well known and trusted by the target 
population.  Many of the survey questions were based on an original survey conducted in 
the region in 2001.  The original survey was designed to gather data to identify needs of 
local injection drug users and provide recommendations for appropriate harm reduction 
strategies.  Appendix B provides a copy of the new survey tool developed for this study.  
This new survey asked questions regarding: baseline demographic data, general 
characteristics of the sample population, access to health services, levels of satisfaction 
with current health care and MMT services, and opinions about methadone.  Although 
the majority of survey questions were closed-ended, some questions did allow for written 
responses and additional comments by participants. 
Qualitative data was collected using focus group sessions, conversations with key 
informants, field notes, and through participant observation.  For example, the researcher 
interacted with the target population beyond the time required to complete the survey 
tool. On several occasions, completion of the surveys resulted in conversations with the 
respondents who were very interested in the research being conducted and welcomed the 
opportunity to share their stories.  Detailed field notes and observations of these 
encounters were documented on a regular basis.  Opiate users (past and present) were 
invited to attend one of two focus group sessions to share their experiences regarding 
opiate use, their experiences with MMT, and their satisfaction with health services 
(including MMT) currently available to them.  Appendix C outlines the guiding questions 
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asked during the focus group sessions.  A more detailed analysis of the focus group 
sessions is presented in Chapter 5.  In addition, an amendment to the original UOIT REB 
application was submitted and approved in order for the researcher to conduct informal 
interviews and engage in conversations with key informants including: a pharmacist, a 
downtown business owner, a member of the downtown business improvement 
association, a Health Unit staff nurse who administers outreach for the target population, 
a street nurse, and opiate users.   
Inclusion / Exclusion Criteria – Surveys and Focus Groups 
 
Individuals who currently used opiates on a regular basis and/or accessed local 
MMT services at either of the two clinics in the community were invited to complete a 
survey and attend one of two planned focus group sessions. The inclusion/exclusion 
criteria for participation in the research study were as follows: 
1. Participants had to be at least 18 years of age 
2. Participants could be male or female 
3. Participants did not complete the survey more than once 
4. Participants had to be currently using opiates and/or MMT services available 
in the research area 
5. Participants were not receiving MMT outside of Hastings and Prince Edward 
Counties, Ontario. 
Recruitment and Sampling Techniques 
  
A targeted convenience sample for this research study was obtained with 
cooperation from local members of the local Injection Drug Users Harm Reduction Task 
Force (HRTF), the MHSN (Belleville Freedom Support Center), local pharmacies who 
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dispense methadone, one of the two methadone clinics in the area, a local street nurse, 
mental health workers, local businesses who agreed to hang posters, and by word of 
mouth.  Both of the local methadone clinics were visited by the researcher and invited to 
put up posters (see Appendices D and E).  Only one of the clinics was willing to take 
part.  Similar declines to invitations to participate in the recruitment of respondents for 
the study were experienced at local pharmacies.  Although three pharmacies were 
approached, only one was willing to participate.  This pharmacy not only hung posters, it 
provided methadone clients with copies of the poster to encourage them to participate in 
the survey.  Several respondents arrived at the Belleville Freedom Support Centre 
(BFSC) with copies of the poster.  For many, it was the first time they had ever visited 
the space.  This was an added bonus as it meant they were also introduced to peer support 
workers, mental health support workers, a safe space where they could eat an affordable 
meal, and meet other individuals experiencing similar challenges.  Posters were also 
placed in public places frequented by the target population as well as storefronts in the 
vicinity of the methadone clinics. 
 Key informants were approached in person or by telephone by the researcher and 
invited to participate in an informal interview to provide their perspectives on MMT 
services available in the community.  Appendix L provides examples of the types of 
questions asked during these semi-structured interviews.  Among those approached were:  
a doctor who prescribes methadone, a local pharmacist, a street nurse, a downtown 
business owner, a local outreach health worker, a mental health and addictions worker, a 
member of the local downtown business improvement association and opiate users.   The 
doctor was the only individual who declined the invitation to participate.   
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 As previously mentioned a similar survey involving members of the same target 
population was conducted in 2001 and yielded 31 respondents.  This study focused on the 
injection practices of IDUs in a number of small towns and cities located in Hastings and 
Prince Edward Counties, Ontario, including Belleville.  Although the study did not solely 
look at opiate use, results showed that opiates (by injection) made up the majority of drug 
use over the previous 12 months (Melinyshyn, 2001).  Key informants speculated that 
this new study would see a similar sample size based on the smaller geographic area and 
the focus on individuals using only opiates.  However, upon conclusion of the 
administration of the new survey, the sample size was 54. 
Research Timelines 
  
Data collection for the research study began in June, 2010.  Posters were placed in 
various downtown locations, word of mouth was instigated and surveys were made 
available to eligible participants between June 1 and July 30, 2010, every Tuesday and 
Thursday (at minimum) from 10:00 am to 3:00 pm.  Completed surveys were collected 
by the researcher on a daily basis.  Focus group sessions were advertised in July, 2010, 
with two sessions taking place in August, 2010.  The majority of data was collected in the 
spring/summer months to allow for seasonal trends associated with drug addiction (Utts, 
2005).  Data analysis commenced in November, 2010 with completion in March, 2011. 
Data Collection 
  
As previously stated, the time and location for the survey and the focus group 
sessions were advertised through word of mouth, posters located in local storefronts, 
needle exchange sites, pharmacies dispensing methadone, downtown businesses, and the 
methadone clinics (see Appendices D and E).  People who expressed interest in 
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completing the survey were interviewed briefly by the researcher or the street nurse to 
confirm eligibility for the study.  It was important to clearly determine eligibility as the 
$20 incentive resulted in several inquiries from persons who did not use opiates or MMT.  
Some people were asked to produce picture identification to verify they were at least 18 
years of age.  People who were not currently using methadone were interviewed by the 
street nurse to determine if their opiate use was significant enough to where the user 
would require assistance, such as MMT, to stop using opiates.   
The street nurse has an extensive background working with opiate users and 
MMT clients.  His expertise in determining eligibility was a crucial component of the 
data collection process.  Eligible respondents were invited to participate in the 
quantitative and qualitative components of the study.  Each participant received a letter of 
invitation and informed consent prior to any participation in any part of the research 
study in accordance with the Tri-Council Policy and UOIT Research Ethics Board 
Guidelines.  A copy of the letters of invitation and the consent forms for participation in 
the survey and focus group sessions are provided in Appendices E and F.  No limit was 
set to the number of eligible participants who could complete the survey.  However, a 
maximum of six participants were allowed to register for each of the two focus group 
sessions. 
Quantitative Data Collection 
 
Development of the Survey Tool 
 
Advice for development of the survey tool was solicited from experts in the field 
and key informants in order to ensure content validity and relevance.  The survey was 
comprised of mainly close-ended questions.  There was an opportunity to assist 
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community stakeholders by including questions comparable to those asked on the 
aforementioned survey conducted by the HRTF in 2001.  These included questions 
regarding participant characteristics and demographic data, injection drug use, and needle 
practices.  In addition, the new survey asked questions about health services currently 
available to users, access to care, experience with opiate use and MMT, and opinions 
about methadone (based on the Opinions About Methadone (OAM) scale). The OAM 
scale is reported by Kayman, Goldstein, Deren, and Rosenblum (2006) as having face 
validity and factorial validity as well as internal consistency reliability and predictive 
ability.  Readability of the survey was confirmed by experts and any changes were made 
based on their recommendations to ensure the reading level and wording was appropriate.  
Organization of the survey questions was implemented based on feedback from field 
experts (Center for Addiction and Mental Health (CAMH).  For example, similar survey 
questions were grouped into categories and sections for better flow and easier data 
analysis.  The final survey used for this study was the result of months of work involving 
several drafts with input from the researcher‟s team of university advisors and field 
experts.  
Prior to making it available to respondents, the survey tool was piloted using a 
test re-test method with individuals who were recruited by the street nurse.  The test re-
test involved an initial completion of the survey by participants who met the inclusion 
criteria for the study followed by a second completion of a new copy of the same survey 
by the same participants two weeks later to identify any areas of inconsistency within the 
survey.  The test re-test analysis was conducted using a Cohen‟s Kappa analysis. 
Combined with the feedback from experts (CAMH, journalist) regarding the readability 
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and content of the survey, the survey was deemed ready for data collection.  Additional 
information regarding the Cohen‟s Kappa analysis is presented in the Quantitative Data 
Analysis section of this chapter. 
Administration of the Survey 
 
The local Mental Health Support Network (MHSN) established dates and times 
for conducting surveys at the BFSC with the researcher and the street nurse.  Surveys 
were advertised as being available to persons meeting the inclusion criteria two days per 
week for six hours per day between June 1, 2010 and July 31, 2010 at the BFSC.  The 
street nurse assisted with the research study by screening potential research participants 
to determine eligibility and assisting with facilitation of the surveys.  This was necessary 
in order to weed out individuals who were solely motivated by the $20 incentive and did 
not qualify for the study.  Some individuals were identified as providing fraudulent 
information during the brief pre-screening process.  The expertise and training provided 
by the street nurse in determining eligibility was instrumental in ensuring the sample was 
correct. 
Each survey was numbered.  No other identifiers were listed on the survey.  All 
letters of invitation and informed consent were kept in a locked file cabinet on site at the 
BFSC in the event confirmation about whether participants had already completed a 
survey was required. Confidentiality was maintained at all times.   The street nurse and 
researcher both signed a confidentiality agreement (see Appendices H and I).  Individuals 
meeting the aforementioned inclusion criteria received a letter of invitation and a letter of 
informed consent (see Appendix F) prior to their participation in the survey.  Completed 
letters of invitation and informed consent were secured in a locked cabinet in a locked 
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office at the BFSC.  Both letters were destroyed upon completion of the data collection 
process.  Each participant was informed of these precautions. 
Participants were offered a private space (if they wished) where they could 
complete the survey.  The street nurse and/or researcher were available to clarify any 
questions regarding the survey and to confirm all questions had been answered prior to 
paying participants $20 for their time.  There was no way to link a survey with a 
participant.  Completed surveys were collected at the end of each research day and kept 
in a secure, locked cabinet at the researcher‟s residence.  Informed consent documents 
were kept in a secured, locked file cabinet at the research site.  The response rate was 
calculated (54 completed surveys) at the end of the quantitative data collection (after July 
31, 2010).  Upon completion of the research and this thesis, any remaining paper and 
electronic information linking individuals to completed surveys will be destroyed 
(shredded and/or deleted).   
Qualitative Data Collection 
 
Two separate focus group opportunities were provided for individuals wishing to 
participate in this study to allow for variance in availability and to improve the chances of 
obtaining enough data for the study.  Advertising the dates, times and location of the 
focus groups was achieved with assistance from the street nurse, a pharmacist who 
dispenses methadone, health workers involved in a local needle exchange program and 
downtown businesses who dedicated space for signage.  The two sessions were held at 
the Belleville Freedom Support Centre (BFSC) in August, 2010.  Sign-up sheets were 
available at the BFSC for individuals who met the aforementioned inclusion criteria.  To 
protect confidentiality, contact information provided by eligible participants (sign-up 
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sheet) was secured in a locked file cabinet at the research site.  Each focus group session 
was limited to a manageable, maximum number of six participants (Bowling & Ebrahim, 
2007).  Although focus group sessions with fewer than six participants may not generate 
a usable amount of data, more than eight participants may result in some participants not 
being able to fully participate (time restraints and volume of information) and/or a 
session that is challenging to manage overall (Bowling & Ebrahim, 2007).  
The local street nurse assisted with the facilitation of the focus group sessions and 
was available to provide care to any participants who might experience emotional distress 
as a result of the process.  Permission was received from all participants for the audio 
recording and the taking of field notes and confidentiality was maintained at all times.  
The street nurse, the researcher and all participants signed a confidentiality agreement 
prior to each focus group session (see Appendices H and I).  Informed consent was 
delivered verbally as well as on paper.  Participants were verbally reassured that none of 
the data collected would reveal any information connecting the research to any individual 
person.  The researcher also signed a confidentiality agreement pertaining to data 
transcription (see Appendix J).  All confidentiality agreements used in this research were 
approved by the University of Ontario Institute of Technology (UOIT) Research Ethics 
Board (REB).  The incentives for attending and participating in a focus group session 
included a free meal and the offer of $20 per person.   
 As previously stated, consent was obtained prior to the use of audio technology in 
order to record the sessions and the confidentiality agreements were signed by all who 
attended including the participants, the researcher, and the research assistant.  Two digital 
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audio recorders were used to capture the exchange (Panasonic RR-US551 „Zoom Mic‟ 
and an Olympus Digital Voice Recorder VN-3100PC).   
 Based on observations and research gathered by the surveys and during the focus 
group sessions, it became apparent that additional information from key informants 
would be necessary in order to place the study in the context of a small city.  It was 
anticipated that this additional data would provide a more complete picture of the issues 
surrounding MMT services currently available in the community as well as provide 
suggestions for specific improvements.  An amendment to the original UOIT REB 
application was submitted and approved.  The amendment outlined reasons why the 
informal interviews were necessary, questions the researcher would ask community 
stakeholders and steps that would be taken to ensure confidentiality and anonymity such 
as informed consent and confidentiality documents.  Appendix L outlines examples of the 
types of questions asked during these informal interviews with key informants.  
Appendix K provides a copy of the letter of informed consent and the confidentiality 
agreement signed by each interviewee and the researcher.  Concerns expressed by 
community stakeholders, their observations and perceptions about the local methadone 
clinics, and their suggestions for improving MMT services in the community are outlined 
in further detail in Chapter 6 of this thesis.   
Data Analysis 
  
The following section discusses the processes used to analyze the quantitative and 





Quantitative Data Analysis 
 
Descriptive statistics and cross-tabulations of selected variables were analyzed 
using the statistical software, SPSS Version 18.  In addition, an online tool was also used 
to conduct the Cohen‟s Kappa analyses of the survey tool.  This analyses used data 
collected during the test re-test process previously mentioned.  The Cohen‟s Kappa 
analyses are used to measure the level of sameness between two sets of ratings or scores 
(Wood, 2007).  For this study, a Cohen‟s Kappa analysis was used to measure responses 
by two individuals who completed the same survey two weeks apart.  Four questions 
were selected from the completed surveys and answers to the same questions were 
compared between Time One and Time Two for both responders.  Three of the four 
questions were answered exactly the same way by respondents both times they completed 
the survey.  This resulted in a Kappa of one for those three survey questions, which 
equates to a high degree of reliability.  However, on one question, there was a slight 
difference in the responses between Time One and Time Two.  This may have been due 
to the nature of the question.  For example, the question asked respondents to rate their 
overall health.  The answers may have varied according to how the respondents were 
feeling at the time they completed each survey.  The small sample size used for this 
analysis (two respondents) is also a factor for consideration.    
Qualitative Data Analysis 
 
During the focus group sessions notes were taken by the research assistant (street 
nurse).  In accordance with the transcription process described by Denzin and Lincoln 
(2000), the data analysis involved listening to the recorded sessions and writing down 
each word, pause, remark and statement to capture non-verbal behaviours during the 
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interview, such as laughter and pauses made by both the researcher, the assistant, and the 
subjects.  Such details are considered an important part of the research process because 
they allow the reader to gain a sense of how the actual conversations played out (Denzin 
& Lincoln, 2000).  The researcher compared the session notes with the audio 
transcriptions during the transcription process for further confirmation of accuracy.  
During the transcription of the audio recordings, each participant, the researcher and the 
assistant were assigned a specific code for easy identification.  For example, the 
researcher‟s guiding questions were coded using the letter „R‟ while subjects‟ responses 
were transcribed using a name or conceptual label that best captured what they had to 
say.  This process was repeated for each focus group session.  Upon completion, a coding 
scheme was developed to capture issues identified by all participants. The transcription 
was generated solely by the researcher.  Due to the low response rate, the analysis of the 
focus group data was achieved manually.  No analysis software was used.  Each 
transcription was divided into segments of categories for comparison across groups based 
on specific questions or areas of inquiry.  Common themes were gleaned from the data 
and grouped together for the final analysis.  The detailed analyses, including quotations, 
are provided in Chapter 5. 
Validation of Data 
         
Allowing research subjects to be included in determining the truthfulness of the 
transcription of the data is regarded as important for validating accuracy of a 
transcription.  This type of validation, through quality checks, has been identified as a 
way to ensure rigor in a study (Dallas, Norr, Dancy, Kavanaugh, & Cassata 2005).  
However, due to the transient nature of the target population for this research study, 
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information from focus groups could not be shared with participants.  Instead, validation 
of accurate transcription and interpretation of the data was achieved by consulting the 
street nurse who attended both meetings and took field notes.  
Strengths Associated with the Research Design 
  
Although the use of surveys to gather data may not be considered as rigorous as a 
Randomized Control Trial (RCT), considering the target population, this approach did 
provide an environment most conducive to data collection.  Surveys were distributed and 
facilitated by a trusted health worker at a location where the participants felt comfortable.  
This strengthened participation and resulted in a larger sample size.  Questions on the 
survey were chosen based on a previous survey targeting the same population and 
geographic area, as well as questionnaires used in research studies, such as the 
aforementioned OAM Scale, specifically targeting illicit opiate users and those receiving 
MMT.  Support for the project from community and health groups (HRTF, MHSN) 
helped to facilitate a better response from the target population.  A ground level 
involvement over a long period of time by the principal investigator allowed trust to be 
established and enhanced the willingness of opiate users to participate in the survey.   
 The mixed method approach employed in this study further strengthened the 
overall research process.  First, qualitative data was used to uncover deeper meanings 
behind the answers provided on the survey.  For example, respondents were able to 
explain their level of satisfaction with MMT services and the reasons for their 
satisfaction/dissatisfaction.   Second, the details provided in the stories and statements 
told by participants provided insight into new directions for future research.  For 
example, focus group sessions provided details about specific suggestions for improving 
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services including better treatment from frontline staff and clinic hours.  Similar 
examples on the usefulness of such strategies are outlined by Bowling and Ebrahim 
(2007). 
Limitations Associated with the Research Design 
  
Limitations associated with this research project include the following.  Relying 
on opiate users to self-report on extremely personal health issues, especially considering 
the stigma surrounding addiction, proved challenging.  Regarding the quantitative data 
collection, limitations included fraudulent representation by respondents in order to 
receive $20 for completion of the survey.  Also, some questions were left unanswered 
early in the study.  Once it was realized that some participants were not providing 
answers to all questions, a decision was made to briefly scan each survey prior to ensure 
questions had not been skipped over by mistake.  Some people may not have been 
familiar with the location of the BFSC which may have resulted in a smaller sample size.   
Although the sign-up sheet for the focus group sessions was full, only seven 
individuals of the 12 who registered actually attended.  Of those, only three had a history 
of opiate use that warranted MMT.  In the other cases, the monetary incentives (money 
and a free meal) may have been the main objective resulting in fabricated or bad data.  
The presence of the street nurse and the researcher may have inadvertently influenced the 
quality and quantity of information participants were willing to share during the focus 
group sessions.  Due to the transient nature of the target population, validation of the 
qualitative data with participants through member checks was not possible.   
For both areas of the research design, findings may not be generalizable to other 
small communities.  Additional research exploring MMT available to respondents with 
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geographical and demographic characteristics similar to this study is needed in order to 
identify any similarities or differences before generalizations about the results from this 
study can be made.  Researcher bias may also be a factor.  Denzin & Lincoln (2000) 
discuss how the mere presence of a researcher may alter/affect responses and actions on 
the part of research subjects.  Being involved with the respondents on such a personal 
level over an extended period of time may affect the researcher‟s ability to remain 
objective; especially when dealing with a vulnerable population. 
Summary 
 
Addiction, including opiate addiction, continues to be a major public health issue 
in Canada (MOHLTC, 2007).  MMT remains the accepted gold standard nationally, and 
globally, for treating the problem (WHO, 2008).  Although most Canadian research has 
focused on populations in major cities, opiate addiction continues to be a public health 
concern in smaller regions, including Hastings and Prince Edward Counties in Ontario.  
This research is important considering the lack of research targeting MMT services 
available to users/consumers in smaller cities and towns.  Upon completion of the 
research, findings may be useful to health professionals (doctors, nurses and 
pharmacists), and community outreach workers (needle exchange programs, street 
outreach).  Finally, and most important, is the potential for positive impact on the lives of 
those suffering from opiate addiction by increasing chances at normalcy, providing better 
health care overall and possibly reducing stigma associated with persons struggling with 
addiction.  
 The following chapters present the results of the quantitative and qualitative data 
that was collected and analyzed.  The research findings are then discussed and 
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The survey for this study was designed to describe the target population along 
several key dimensions:  1) basic demographics, quality of life, 2) health and health care, 
3) opiate use (past and present), 4) experience with methadone maintenance treatment 
(MMT) (including level of satisfaction), 5) experience with social services, 6) the 
importance of availability of specific health services in the community, and 7) opinions 
about methadone.  The following tables represent the data collected for each category and 
some provide comparison of certain cases, for example: males and females, and 
individuals who are receiving methadone and those who are not.  Of the 54 surveys 
completed, one survey was deemed unusable based on answers regarding past/present 
opiate use.   
Sample Population Demographics 
 
Age, ethnicity, education, income level, sources of income, living arrangements, 
relationship status and family considerations were analyzed under the category of 
„sample population demographics‟.  Table 1 summarizes the demographic characteristics 
of the sampled population.  Many of the characteristics parallel those used to describe 
most opiate users in other studies.  Specifically, low income (poverty), homelessness, 
education level, lack of solid support systems, and use of other substances are among the 























 18 – 29  
 30 – 39 































  6 (11.3%) 
2 (3.8%) 
EDUCATION COMPLETED 
 Public School 
 High School 












 7 (13.2%) 
INCOME LEVEL 
 $0 - $19,000 
 $20,000 - $59,000 













SOURCES OF INCOME 
 Regular / occasional employment 
 Social Assistance / welfare 
 Long term disability (ODSP) 

















 Homeless in past 30 days 
 Shelter / boarding house 
 On the street 
 Rent an apartment / room 
 Stay with friends / family 




















             42 
2 
  0 
**FAMILY/ RELATIONSHIP STATUS 
 Meaningful relationship 
 Respondents with Children <19 














     **Not all respondents provided answers or more than one answer chosen for the    
         question 
 
Age categories ranged from under 19 years to 50+. The majority of the sample 
(35, 71.8%) was 40 – 49 years of age.   Thirty-eight (71.8%) of respondents were male; 
only 15 (28.3%) were female.  Forty-five (85%) of the respondents identified their 
ethnicity as white; six (11.3%) were Aboriginal / Native Canadian and two (3.8%) were 
of mixed ethnic background. The vast majority (47, 88.7%) reported their total income 
for 2009 as below $19,000 with most of the income provided by a variety of social 
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services including the Ontario Disability Services Plan (ODSP) and Ontario Works 
(welfare/social assistance).  Other sources of income included regular employment and 
illegal means, such as prostitution.  Just six (11.3%) identified themselves as being 
homeless during the past 30 days.  Many of the respondents reported their 30-day living 
arrangements as a mixture of renting a room, staying with friends, staying in a shelter 
and/or sharing an apartment. Of the 21 respondents with children under the age of 19, 
only seven (13.2%) said their children currently lived with them.  
Opiate Use and Injection Practices 
 
Of the 53 respondents, 52 (98.1%) reported opiate use; 23 (44.2%) currently use 
opiates, 29 (54.7%) have used opiates in the past and one individual chose not to respond.  
Table 2 provides an overview of opiate use among the sample population. 













        23 (43.4%) 
        29 (54.8%) 
**TYPE OF OPIATES  (Past and Present) 
 Heroin 




  7 (13.2%) 
        26 (49%) 
10 (18.9%) 









** PROBLEMS ASSOCIATED WITH YOUR OPIATE USE 
 Financial 
 Relationship  
 Career/Employment  
 Legal 













  The response to the question regarding current opiate use is important as it 
suggests there are individuals in the community who might benefit from participating in a 
MMT program but are not currently accessing these health services.  This point is 
supported considering 24 (46.2%) of the respondents indicated they have never 
participated in a local MMT program (Table 3).  The survey also revealed use of 
prescription opiates (OxyContin and morphine) was more prevalent than the street drug, 
heroin.  Seven respondents (13%) reported heroin as their opiate of choice compared to 
36 (67.9%) who identified prescription opiates.    
Unlike OxyContin, percocet/percodan which are likely to be snorted or taken 
orally, morphine and heroine are often used via intravenous injection.  Twenty-two 
(41.5%) of the respondents reported using drugs intravenously with six (27.3%) of these 
sharing needles and six (27.3%) sharing works.  The term, works, is specific to 
intravenous drug use and refers to syringes and other drug paraphernalia required for 
preparation and injection of a drug.  It is vital to understand current injection practices, 
including where users obtain their works and if works are shared among users.  Many 
studies have been conducted on injection drug use and clearly identify the risks and 
harms associated with unsafe injection practices including sharing needles and other 
works, inappropriate discard of used needles, etc. (see Pauly, 2007; Millson et al; RNAO, 
2009).   Data gathered from this research study may be useful to allied health 
professionals involved in current local harm reduction strategies.  Needle Exchange 
Programs (NEPs) track the number of syringes given to/returned by users and drug kits 
provided to users in the community.  Future research focused on needle disposal and 
injection practices may provide the basis for improving harm reduction strategies for 
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injection drug users (IDUs) within communities.  Local needle exchange sites (inside 
pharmacies) were used most often by the 22 respondents identified as IDUs (21, 95.5%).  
Only five (22.7%) reported obtaining their needles from a dealer or friend. 
It is notable that 10 (18.9%) of the respondents chose not to answer the question 
about the types of opiates they used.  The reasons for this may include fear of being 
identified as using other drugs while being in an MMT program, embarrassment, or fear 
of being judged.  Stigma associated with opiate use and MMT persists among health care 
workers and the general public and has been identified as a barrier to treatment (RNAO, 
2009).   Despite re-enforcing confidentiality and receiving informed consent from 
respondents prior to their participation in the survey, participants know there exists a real 
possibility of being cut off of methadone should clinic physicians learn they are using 
opiates, or other drugs, while on the program.  Data gathered during focus group sessions 
for this study supports this statement.   
It is important for communities to monitor the types of drugs being used by 
consumers in order to identify any increase in harms associated with a shift in trends.  
Current trends in opiate use in North America lean towards an increase in the abuse of 
prescription opiates over heroin.  From 2003-2005 Canada was ranked third in the world 
for prescription opiate use (Fischer, Gittins, & Rehm, 2008).  Results of this current 
research study identified similar trends in Belleville, Ontario, regarding the shift to 
prescribed opiates. For example, 29 (46%) of the respondents identified prescription 
opiates as their drug of choice compared to 7 (13.2%) who identified heroin.  Future 
studies focused on the illicit use of prescription opiates in smaller Canadian cities may be 
warranted.   
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Opiate use affects many aspects of a person‟s life:  financial, professional, 
interpersonal, and private.  When asked about specific areas of their life that have been 
affected by opiate use, 45 (84.9%) reported financial problems, 30 (56.6%) reported 
relationship problems, 22 (41.5%) reported career/employment problems, 25 (47.2%) 
reported legal problems and 25 (47.2%) reported mental health problems.   There were no 
significant differences in opiate use between men and women.  This may be due, in part, 
to the small sample size and may be grounds for future studies in order to verify any real 
discrepancies about opiate use between males and females.   
Respondents’ Experience with Methadone Maintenance Treatment Programs 
 
Relapse is a common occurrence among individuals struggling with all manners 
of substance abuse; tobacco, alcohol, drugs, etc. (Pauly et al., 2007).  When referring 
specifically to opiate addiction, options available to individuals who wish to stop using 
are limited.  Choices include attempting to wean oneself off of a substance without 
medical support, stopping „cold turkey,‟ and medically supervised substitution therapy 
such as MMT.  Enrolment and retention in MMT programs is shown to be directly related 
to: attitudes and opinions about MMT and what it can do, interaction with frontline MMT 
workers (doctors, nurses), the dosage prescribed (if it is sufficient enough), and access to 
carries (Pauly et al 2007; RNAO, 2009; Kayman et al, 2006).  Having access to carries 
profoundly affects an individual‟s experience with MMT.  The ability to take home 
medication and avoid having to visit a clinic or pharmacy seven days per week allows 
individuals to lead a more normal life both personally and professionally.  As previously 
mentioned in Chapter 1, there are guidelines for prescribing carries to clients.  This study 
revealed that 21 (75%) of the 28 respondents received carries after only weeks in a MMT 
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program, three (10.7%) were granted carries after a number of months and four (14.3%) 
have never had carries. 
Table 3 provides an overview of the responses to questions on the survey related 
to experience with MMT programs.   







LENGTH of TIME USING MMT? 
 < 6 months 
 6 months – 23 months 
 24 months – 84 months  
 
     5 (17.9%) 
     9 (32.1%) 
14 (50%) 
 
NUMBER of TIMES STARTING MMT 
 1 – 3 
 4 – 6 
 
   25 (89.3%) 
     3 (10.7%) 
 







**REASONS for DIFFICULTY STICKING with MMT 
 Due to illness 
 No support (health care providers, family, friends) 
 I was not ready to start a program 
 Program full/ didn‟t start right away 
 I was still using opiates 
 No transportation  










LENGTH of TIME with MMT BEFORE CARRIES 
 Carries allowed after a number of weeks on MMT 
 Carries allowed after a number of months on MMT 
 Carries never allowed  
 
21 (75%) 
     3 (10.7%) 
     4 (14.3%) 
        **Respondents may select more than one answer to the question 
 
Of the 53 respondents, 28 (52.8%) identified themselves as having experience 
with MMT, 14 (50%) reported being in the program between 24 and 84 months with 25 
(89.3%) having enrolled in MMT up to three different times.  The number of individuals 
who did and did not experience difficulty sticking with an MMT program was split in 
half.  The 28 respondents with MMT experience identified several reasons for difficulty 
sticking with an MMT program.  For example, seven (25%) identified lack of supports, 
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seven (25%) cited illness, four (14.3%) were not ready to start the program, four (14.3%) 
stated the program was full or did not start right away, and two (7.1%) were still using 
opiates.  Other reasons included lack of transportation and fear of losing their income.  
Although some insight into the details surrounding these answers was obtained in the 
focus group sessions, future studies focused on this area may provide useful information 
for improving services and possibly increasing enrolment and retention in MMT 
programs.   
In addition to individuals‟ experience with MMT, data was also collected and 
analyzed regarding individuals in the community who may benefit from MMT but are not 
utilizing the services available to them.  It is worth noting that 24 (45.3%) of the total 
sample indicated they had never accessed MMT services.  Considering the overwhelming 
empirical evidence related to the benefits of MMT, it becomes extremely important to 
explore why opiate users would choose not to access these services; especially those 
available in their community.  Based on an existing 14 question Opinions About 
Methadone Scale (OAM Scale), Kayman et al. (2006) developed a modified version 
using five of the questions (OAM5) shown to be most closely related to an individual‟s 
decision on whether or not to enter a MMT program and subsequently stay with a 
program.  Chapter 3 details the OAM5 Scale analysis. Table 4 outlines the OAM5 Scale. 
Table 4 OAM5 Scale 
 
OAM5 Scale 
1. It is safe to take methadone 
2. Methadone takes away the craving for opiates like heroin and OxyContin. 
3. With methadone, you can eventually get off of illegal drugs. 
4. Methadone has proven to be the best way of quitting opiates like heroin and OxyContin. 
5. Methadone helps us lead a normal life 
         Kayman et al. (2006) 
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Following Kayman et al (2006), this analysis attempted to reproduce the OAM5 
Scale to assess the relationship between opinions about methadone and methadone use.  
The five key items were selected and reliability for the study was assessed.  Results 
showed a Cronbach‟s Alpha of .816 which indicates the scale has strong reliability.  The 
OAM5 scale scores were found to significantly correlate with methadone use:  r = .356* 
and p = .010.   In other words, opiate users with more favourable opinions about 
methadone are also more likely to be accessing MMT.  It is unclear whether these 
favourable views influence opiate users to enter MMT programs or whether participation 
in these programs influences more favourable attitudes.  Although this data only suggests 
a relationship between OAM and MMT enrolment, it is consistent with data presented by 
Kayman et al. (2006) which suggests a causal relationship between OAM and MMT use.   
Respondents’ Experiences and Satisfaction with MMT Health Services 
 
In addition to questions regarding experience with MMT, respondents were also 
asked to rate their level of satisfaction with the MMT services they currently access.   
Analysis of the survey questions regarding satisfaction with MMT services 
revealed that 17 (60.7%) of the 28 respondents were dissatisfied, nine (32.1%) were 
satisfied, and two (7.1%) did not respond.  There is considerable evidence to support the 
provision of counselling as part of MMT programs as a key factor in successful 
outcomes, including retention in programs and reduction in rates of relapse (CAMH, 
2008; CPSO, 2005; Gossop, Stewart & Marsden, 2006; Graham, 2007; RNAO, 2009).  
Guidelines exist for inclusion of counselling as part of MMT in Ontario (CPSO, 2005).  
However, responses to survey questions about counselling as part of their MMT program 
were as follows:  10 (35.7%) received counselling services within the MMT clinic, while 
66 
 
14 (50%) received no counselling at all.  Furthermore, only 14 (50%) were offered 
structured counselling as part of their MMT program and just 13 (46.4%) were ever 
referred to counselling outside of their MMT program. Table 5 outlines participants‟ 
experience and satisfaction with MMT health services. 
Table 5: Respondents’ Experiences and Satisfaction with MMT Health Services*,  






n  (percent) 
 
COUNSELING SERVICES PROVIDED as part of MMT? 
 Counselling services within the MMT clinic 
 Counselling services outside the MMT clinic 
 Referral to physicians 
 No services provided 





            14 (50%) 
              1 (3.6%) 
 
WERE YOU EVER OFFERED STRUCTURED COUNSELING as 
PART of an MMT PROGRAM? 
 Yes 
 No / No answer provided 
 
 
             14 (50%) 
             14 (50%) 
 
REFERRED to COUNSELING OUTSIDE of an MMT PROGRAM? 
 Yes 





**REASONS MMT CLIENTS MISS APPOINTMENTS with    
      HEALTH PROFESSIONALS 
 I forgot 
 I was too high / on the “nod” 
 I was too tired / sleeping 
 No transportation / no child care 
 I felt mistreated and/or disrespected by the health care provider 




              7 (25%) 
2 (7.1%) 
  3 (10.7%) 
2 (7.1%) 
  3 (10.7%) 
 
HOW SATISFIED WERE YOU / ARE YOU WITH the MMT 
SERVICES YOU RECEIVED? 
 Satisfied 
 Dissatisfied 
 No answer provided 
 
 
 9 (32.1%) 
            17 (60.7%) 
              2 (7.1%) 
 
        ** Respondents may select more than one answer to the question 
 Reasons why individuals miss appointments with health care professionals, 
including MMT appointments, may be related to satisfaction and so are included in this 
section of analysis.  When asked why clients miss their appointments, the following 
reasons were given; the majority of responses, 10 (35.7%), indicated that clients forgot 
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about their appointments, seven (25%) indicated they were too high or „on the nod‟ (a 
physical response to using opiates), and three (10.7%) did not want the health care 
professional to know they were still using drugs.  It is not uncommon for MMT clients to 
be using other drugs (cocaine, marijuana, etc.) while in a treatment program.  A urinalysis 
may reveal the use of substances and may be grounds for dismissal from the program.  
Three respondents (10.7%) indicated no transportation or access to child care, and two 
(7.1%) did not attend due to lack of respect or feelings of judgment on the part of the 
health professional toward the client.  It is important to note that respondents were able to 
choose more than one answer to this question.  Understanding why clients miss 
appointments may help frontline workers identify ways to support clients and improve 
adherence to program policies.   
Access to Health Care Services for Respondents 
  
Substance abuse, including opiates, is defined by Pauly (2008) as a chronic illness 
of which relapse is common occurrence.  When viewed as a long-term illness requiring 
medical attention versus a poor personal choice deserving of punitive consequences, 
physical and mental health issues associated with the illness and their 
management/treatment must be considered.  Decisions about whether or not to seek 
medical attention starts with an individual‟s assessment of his/her own health.  For the 
purposes of this study, responses were separated into two categories; individuals 
currently access MMT and those who are not.  Surprisingly, there was no significant 
difference between the two groups. Table 6 provides an overview of how respondents 
rated their overall health. 
68 
 







n = 28 
 
NON-MMT 
n = 25 
 
N (percent) 
N = 53 
GENERALLY SPEAKING, HOW WOULD 
YOU RATE YOUR OVERALL HEALTH? 
 Excellent 
 Very good 
 Good 




  1 (3.57%)   
  4 (14.2%) 
10 (35.7%)  
  7 (25%) 
  6 (21.4%) 
 
 
   1 (4%)  
   3 (12%) 
 12 (48%) 
   5 (20%) 
   4 (16%) 
 
 
      2 (3.8%) 
      7 (13.2%) 
    22 (41.5%) 
    12 (22.6%) 
    10 (18.9%) 
 
Overall, respondents rated their overall health as follows: two (3.8%) rated their 
health as excellent, seven (13.2%) as very good, 22 (41.5%) as good, 12 (22.6%) as fair 
and 10 (18.9%) as poor.  In addition to the illness of addiction, there exists certain health 
conditions directly related to opiate use over the long term.  The survey provided 
respondents with a list of common ailments associated with opiate use and invited them 
to indicate all medical conditions they felt applied to them as a result of their opiate use.  
Of the 53 respondents, nine (17%) selected open skin sores (abscess) which are common 
among IDUs, 10 (18.9%) experienced overdose, 14 (26.4%) indicated stomach problems, 
seven (13.2%) have experienced some type of Hepatitis infection, and two (3.8%) 
identified themselves as HIV positive. 
 Considering the mental and physical health challenges faced by chronic opiate 
users, it is important to understand what health care services are being accessed and 
where individuals go when they need medical attention.  In order to ensure current 
services can meet the needs of these individuals, it is important to understand if other 
services (i.e. emergency rooms, walk-in clinics, etc) are fulfilling health care roles that 
may be best served by other means.   Respondents were asked to identify which places 
they rely on most when sick or have a health problem.  Table 7 outlines where 
individuals go for primary health care needs and acute medical issues. 
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Table 7: Health Services Accessed for Sickness/Health Problems by Respondents*,  







WHICH PLACES DO YOU RELY ON MOST WHEN YOU 
ARE SICK/HAVE A HEALTH PROBLEM? 
 Hospital Emergency Room 
 Family Physician 
 Methadone Clinic 
 Walk-in Clinic 





  6 (11.3%) 
12 (22.6%) 
12 (22.6%)        
           *Respondents may select more than one answer to the question 
 
Respondents were also provided with a list of local health and social services and 
asked to select all they have accessed in the past 12 months.  Methadone clients were 
compared with opiate users who are not currently accessing MMT.  There was no 
significant difference between the two groups.  Responses to this question varied.  Table 
8 outlines the responses based on the total sample size of 53 respondents.    
Table 8: Local Health/Social Services Accessed by Respondents: Past 12 Months*,  







WHICH SERVICES HAVE YOU USED in the PAST 12 MONTHS? 
 Mental Health Programs 
 Needle Exchange Programs 
 Food Bank 
 Methadone Program 
 Addiction Programs 
 Meal Programs 
 Social Services (Ontario Works, Counselling) 
 Additional Services (detox, sex health, churches 
 
12 (22.6%) 







          *Respondents may select more than one answer to the question 
 The services most accessed by respondents were:  local food banks (31, 58.5%), 
local meal programs (24, 45.3%), social services such as Ontario Works and counselling 
(24, 45.3%) and needle exchange programs (18, 34%).  Mental health programs and 
addiction programs were also accessed (12, 22.6% and 13, 24.5% respectively).   
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The final closed-ended question on the survey asked respondents to rank the 
importance of the availability of a list of health services; some services listed are 
currently available in the community and some are not.  For purposes of analysis, 
answers provided for the choices, „slightly important‟ and „moderately important‟ were 
collapsed into one response as well as the options, „very important‟ with „extremely 
important‟.  Table 9 provides an overview of the information gathered from respondents 
regarding this question. 
Table 9: How Important is it that the Following Services are easily Available to     














Safe Injection Site   7 (14.6%)        10 (20.8%)      31 (64.6%) n = 48 
Needle Park 19 (42.2%)          8 (17.8%)      18 (40%) n = 45 
Harm Reduction Drug Treatment   4 (8.3%)        12 (25%)      32 (66.7%) n = 48 
Clean Works   4 (9.1%)          6 (13.6%)      34 (77.3%) n = 44 
Drug Treatment - Abstinence   5 (10.9%)        12 (26.1%)      29 (63%) n = 46 
Medical Detox   2 (4.2%)          9 (18.8%)      37 (77.1%) n = 48 
Aboriginal Drug Treatment Center   5 (10.6%)        10 (21.3%)      32 (68.1%) n = 47 
Methadone Treatment Program   3 (6%)          6 (12%)      41 (82%) n = 50 
Nutritious Food Supplies   2 (4.2%)          4 (8.3%)      42 (87.5%) n = 48 
Street Outreach   0        13 (27.7%)      34 (72.3%) n = 47 
Needle Exchange   4 (8%)          7 (14%)      39 (78%) n = 50 
Overnight Shelters   2 (4.3%)          7 (14.9%)      38 (80.9%) n = 47 
Welfare/Ontario Works/ODSP   0          7 (14.6%)      41 (85.4%) n = 48 
Health Care Services   1 (2%)        14 (28.6%)      38 (77.6%) n = 49 
HIV Testing   3 (6%)          5 (10%)      42 (84%) n = 50 
Hepatitis Testing   2 (4.1%)          4 (8.2%)      43 (87.8%) n = 49 
Hepatitis B Vaccine   3 (6.5%)          4 (8.7%)      39 (84.8%) n = 46 
Birth Control   7 (15.6%)          5 (11.1%)      33 (73.3%) n = 45 
Free Condoms/Dental Dams   4 (8.3%)          7 (14.6%)      37 (77.1%) n = 48 
      *Respondents may choose to answer more than one question or not at all 
 
Of note are the highest ranking responses rated very/extremely important.  These 
include nutritious food supplies (87.5%), Hepatitis testing (87%), Welfare/Ontario 
Works/Ontario Disability Services Program (ODSP) (85.4%), Hepatitis B Vaccine 
(84.8%), HIV testing (84%), methadone treatment program (82%), and overnight shelters 
(80.9%).  On the other end of the scale were services rated as „not important‟.  The 
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highest response in this category was given to the suggestion of a needle park with 19 
(42.4%) responses. 
Open-ended Survey Questions 
  
The final three questions on the survey were intended to give respondents an 
opportunity to comment and expand on some of the previous questions they had 
answered.  Specifically, the questions asked for suggestions, opinions and input into:  1) 
how access to methadone treatment in the community might be improved, 2) how 
services available at local methadone clinics might be improved, and 3) any additional 
suggestions and comments respondents might like to share regarding needs, access to 
services, services in general, etc.  Of the 53 respondents surveyed, 48 (90.6%) took the 
time to answer at least one of these questions.  Respondents were able to answer one or 
more of the questions and some provided the same answer for questions one and two.  
For this reason, only the number of responses received for each common response/theme 
is reported and as such, no „n‟ or percentage of „n‟ is factored into the analysis.  Rather, 
the number of responses for each common response/theme is given in descending order.  
Twenty responses indicated improving access to current MMT services would 
involve better hours and/or longer hours of operation by the clinics.  In addition, 15 
similar responses, more hours/better hours/accommodation for clients who work, were 
stated for question two.  Some of these responses were given by the same individual.  It is 
interesting that the theme, „better hours,‟ is seen by respondents as having the most 
impact on accessing and improving services at local MMT clinics.  Similarly, 
respondents identified friendlier staff (17 responses in total) and additional MMT 
locations (15 responses in total) as important factors related to improving both access and 
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services.  Table 10 summarizes common responses and themes identified from the 
answers provided. 











What, in your opinion, can be done to 
improve the access to methadone in your 
area? 
 
Better hours/longer hours 
More locations in smaller towns 
Friendlier staff 
More information available on MMT 
Move the clinic for privacy 
Help with transportation 
More doctors at the clinics 












What could be done to improve the 
services available to clients at the 
Methadone Clinics in Belleville? 
 
More hours/better hours/accommodate people who 
work  
Friendlier staff 
More staff/ more doctors  
More clinics (locations) 
Offer additional health services at the clinics 
No wait time before starting the program 
Ensure clients take their methadone and are not 
selling it 












Finally, do you have any other comments 
/ suggestions regarding your needs, 




The following are some of the more 
representative responses to this question. 
 
 
 Very helpful, very beneficial 
 Grateful for access to MMT services 
 Less waiting time.   
 Have staff who care 
 More addiction workers in Belleville 
 Should be able to walk into any clinic when it works with 
your schedule and get your drink 
 “We need a man‟s shelter in Belleville” 
 
*Respondents may choose to answer more than one question or not at all 
Summary 
  
Considering all of the survey data that was collected and analyzed, I was able to 
construct a general composite of the quality of life individuals who participated in the 
survey.  A typical opiate user in small town Ontario would most likely be a Caucasian 
male in his 40s. His name is Bob.  Bob is 43 and has an annual income below $19,000.  
Bob is unable to work.  He collects social assistance or is on long-term disability.  Bob 
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survives because he has been receiving MMT for at least two years and accesses local 
food banks and other social services for monetary and emotional support on a fairly 
regular basis.  Due to his substance use issues, Bob does not have access to carries and so 
schedules his time (seven days per week) around what time he can get to the clinic or 
pharmacy to get his drink.  Bob does not own a car and cannot afford transit so he „bums‟ 
rides, hitch-hikes and/or walks to get his methadone.  When Bob has to keep his 
appointment with the MMT physician (once every two months) he must enter the clinic 
located on the main street in plain view of all the local shops and outlets.  He feels 
exposed and vulnerable.  Bob has lived in the area all of his life.  Chances are high that 
he will meet someone he knows downtown and everyone knows you only go into „that‟ 
building for one reason.  Despite the challenges (stigma/ discrimination) Bob faces as a 
MMT patient, he is grateful.  He is no longer an intravenous drug user.  Although making 
it to the clinic seven days a week is difficult, to say the least, and Bob‟s life is profoundly 
limited by finances, he knows how much worse things could actually be.  He has already 
been there.  For the moment, Bob would rather have his life revolve around getting to the 
clinic for his drink than trying to find ways (including illegal ways) to raise the cash to 
get his daily fix.  He does not miss all of the things that go with that type of existence: 
poor mental and physical health, trouble with the law, fear of overdose, fear of 
contracting blood borne illness, etc.  Being on MMT has given Bob a new start.  His 
health is better (overall), and he is somewhat hopeful about his future.  One response to 
the final open-ended survey question nicely sums up this chapter: 
When our society can recognize that drug addiction is a social medical problem, 




 The open-ended survey questions provided an opportunity for respondents to 
expand on their experiences with opiate use, MMT (where applicable), and some of the 
challenges and barriers they face on a regular basis.  Although this information provided 
some insight into the human side of the issues, it was somewhat limited.  The following 
chapter expands further on the personal experiences of respondents by presenting the 































Without the supplementation of qualitative data, there would be a lack of insight 
into how certain issues broadly impact a person‟s daily life.  It becomes important to 
include qualitative research methods to obtain answers to questions on a broader level; 
especially when the research is focused on human problems and exploring ways to 
improve the quality of life for a population (Denzin & Lincoln, 2008).  Therefore, 
interviewing opiate users for this study was necessary to provide context for the 
quantitative survey data.  For example, failure to expand on the answers to the closed-
ended survey questions for this study would have resulted in a limited understanding of 
experiences with current MMT programs from the perspective of opiate users in HPEC.  
To maintain confidentiality, all participants will be identified using pseudonyms.  The 
following quote from one focus group participant illustrates the importance of including 
qualitative information.   Jim expressed his experiences with opiate use and MMT by 
stating: 
If you want to make yourself clean and keep yourself out of the criminal life, you 
can still be on methadone and still be part of criminal part of society.  But at the 
same time, if you‟re on methadone, it helps you stay clear there „cause you don‟t 
have to be out looking for illegal substances to make you not sick. 
 
I‟m not in jail because of my crimes, doin‟ whatever I had to do to make sure I 
had a pill to make sure I had money to buy dope.  For one, I‟m not sick all the 
time and I‟m not using intravenously anymore. 
 
The closed-ended survey questions did not provide an opportunity for respondents 
to provide answers beyond the options that were presented.  In other words, there was no 
opportunity given for expanding on a response or on an idea. By agreeing to participate in 
a focus group session, opiate users contributed to the expansion of the survey data in a 
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meaningful way by placing questions about opiate addiction, their use of MMT to 
manage their addiction, and their satisfaction with the MMT programs available to them.   
Survey research is well-established but can easily fall short on providing insight 
into the reasons why respondents choose the answers they do (Morgan, 1991).  
Qualitative inquiry provides an opportunity for participants to explain why specific 
answers are chosen from those listed on a survey, thereby providing context and fuller 
meaning to the survey data.  For example, several respondents indicated lack of 
transportation as a barrier to access to MMT services from a list provided on the survey.  
Without the addition of qualitative inquiry, responses to this question may have simply 
been presented as a one-dimensional statistic. This was most evident when a focus group 
session revealed that circumstances require some individuals to hitchhike from outlying 
areas twice a day, seven days per week, 365 days per year, regardless of weather 
conditions or their state of health, in order to make it to the clinic or pharmacy for their 
daily dose of methadone.  Clearly, without this vital piece of contextual information, it 
would be difficult to consider all of the reasons why transportation may be an issue for 
individuals and to what degree this barrier to accessing MMT affects their daily lives.  
Thus, data collected from focus groups involving questions that expand on those asked on 
a survey can be used to enhance the overall study (Morgan, 1991).   
Focus Group Data Analysis 
 
As previously discussed in chapter 3, two focus group sessions took place at the 
local drop-in centre. Posters were provided to the local methadone clinics, the pharmacies 
that distribute methadone, local businesses and the Freedom Support Centre in order to 
recruit participants.  Word of mouth was also used to encourage registration.  Sign-up 
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sheets were available at the Freedom Support Center for persons who met the inclusion 
criteria which included individuals who were over 18 years of age, chronic illicit opiate 
users, and /or a past or present MMT client. Smaller numbers allow for more manageable 
focus group sessions and ensure there is enough time for all involved to have their input 
on the topic (Bowling & Ebrahim, 2007).  Both sessions had six participants confirmed 
for attendance.  Phone calls and face-to-face reminders were provided in the days prior 
to, and on the day of, each the session. Cash incentives of $20 per person and a free meal 
may have played a role in their decision to take part in the study.  All of the people who 
participated in the focus group sessions were receiving some sort of government 
assistance (welfare, Ontario Works, disability, etc.) and had yearly incomes below 
$19,000 per year.  Even with all of the preliminary preparation, attendance was low.  For 
the first session, three of six registered participants attended.  For the second session, four 
of six attended.  What was even more disturbing was that, even though respondents were 
screened for eligibility, a total of four of the seven who attended had never used MMT 
and had limited experience with opiate use.  Health issues, transportation, forgetfulness, 
and drug use may be some of the reasons that some participants were unable to attend.  
All of these were identified in the survey as reasons why opiate users miss appointments 
with health professionals. 
The local street nurse, who services communities in Hastings and Prince Edward 
Counties, attended both focus group sessions in order to take notes and to provide 
assistance for the participants should they experience any emotional trauma during the 
interview.  Prior to each session, the street nurse signed a Research Assistant 
Confidentiality Agreement, the Principle Investigator signed a Transcription 
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Confidentiality Agreement and each respondent signed a letter of informed consent.  To 
confirm informed consent, the principal investigator explained the procedure at the 
beginning of each session, reiterating that confidentiality was paramount and that 
respondents could leave the session at any time with no penalty or negative consequence.  
All confidentiality documents were secured in a locked file cabinet in a locked office at 
the BFSC.  Ground rules for each session were explained to ensure the sessions ran 
smoothly and each individual had equal opportunity for sharing their experiences. 
Specifically, participants were asked that only one person would speak at a time, no real 
names were to be used, and respect for differences of opinion was to be observed. 
The sessions focused mainly on experiences with local MMT services.  The 
questions asked were related to a participant‟s access to MMT services, their personal 
experience with MMT, opinions about MMT, and recommendations for improving MMT 
services available in Belleville, Ontario.  However, due to the fact that not all participants 
had personal experiences with MMT, some questions were asked about other experiences 
with methadone including: 1) obtaining and using the drug illegally (on the street), 2) 
experience with friends who were receiving MMT and, 3) observations and opinions of 
MMT as part of their sub-culture.  Sub-culture is formed when members of a population 
(community) deviate from the larger, social norms (Encylopedia.com, 2011).  In this 
case, although not all respondents are opiate users, 100% consume other illicit drugs on a 
regular basis and as such, are part of the drug sub-culture in the community which 
includes opiate users. 
The focus group sessions were recorded using two digital recorders (Panasonic 
RR-US551 „Zoom Mic‟ and an Olympus Digital Voice Recorder VN-3100PC).  The 
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audio recordings were transcribed verbatim.  Each respondent was coded as follows, R1, 
R2, etc.  No names or other means of identification were included in the written 
transcription of the data.  Common themes were drawn from the responses.  Answers 
were also grouped according to questions asked.  The following analysis outlines the 
common themes gleaned from the data collected as well as answers according to the 
common questions asked. 
Common Themes Gleaned from Answers to Guiding Questions 
 
When asked what changes they would make to current MMT services available to 
them in Belleville, the responses were fairly consistent among the participants.  A 
common concern among participants was that of feeling inferior to frontline nursing staff 
at the local clinics.  These sentiments were reflected in responses to the open-ended 
survey questions where respondents were asked to offer suggestions for improving 
current services.  Frontline nursing staff is responsible for greeting clients as they enter 
the facility, for administering certain drug screening tests and for dispensing prescribed 
doses of methadone to patients.  Changes to front line staff was suggested by all who 
currently access local MMT services.  In particular, MMT clients suggested that front 
line nurses should: 1) have more training on how to work with opiate addicts; 2) have 
some personal experience, if possible, in order to provide peer support; 3) have a 
background in outreach/street nursing; and 4) have a true passion for working with 
methadone patients versus just collecting a pay check.  The attitude of the nursing staff 
clearly impacts the MMT clients‟ experiences.  Jim described his experiences by stating: 
I prefer to have more nursing staff this, say, like Frank (street nurse), that‟s 
actually been in our footsteps that have actually been there and know what we‟re 
experiencing.  Not somebody to say, „you never done opiates, well, I still want the 
job „cause I‟m an RN.  Okay, you‟re an RN so we‟ll hire you „cause you‟re an 
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RN‟, but you don‟t know what we‟re dealing with or why we‟re there for the 
methadone. 
 
A similar response was provided by another MMT client, Kathy, who said: 
The attitude of the staff really sucks.  Like, it changes.  Like, one day they‟re all 
cheery.  
It‟s like, you gotta‟ walk in on egg shells.  Okay, what‟s it gonna‟ be today?  Are 
they in a mood or am I okay? 
 
...just more compassion from staff and reasonability and um, just, people, like you 
said, that know what we‟re going through and have more compassion you know 
and not just look at us like we‟re a junkie and a piece of dirt you know like we‟re 
disgusting and ugh, you know... 
 
Further, a third MMT client, Rachel, expressed her experiences this way: 
I went to First Step.  They said, “We don‟t want you here.”  They wouldn‟t even 
let me in.  I guess they know me. 
 
 When asked about their access to MMT services and any barriers that may exist 
regarding access to MMT services, the following responses were consistent between the 
two sessions: 1) being refused treatment or terminated from of a program for bad 
behaviour; 2) limited hours of operation at the local clinics which affects a patient‟s 
ability to fit their daily visit to the clinic into a regular work schedule; 3) permission to 
have „carries‟; and 4) the health status of the patient due to other addiction and health 
issues.  Participants responded to questions regarding access to MMT services in the 
following ways.  For example, Jim described his experiences as: 
I go to Kingston.  I get my drink in Trenton (Hastings and Prince Edward 
Counties) but my doctor is in Kingston. 
 
You can always get your drink.  I mean, by law they have to give you your drink 
and take you into the program.  I don‟t have a problem getting my drink it‟s just 
the staff attitude.  I‟m having trouble now with transportation „cause I‟ve been 
excused from the program at OATC „cause of my attitude but that‟s because of 




I blew up.  Most people blow up there once or twice.  I blew up six times there 
and I threw my urine on the floor and told her to test it now and I got excused 
from the program so I have to go to Kingston to see a doctor there and I have to 
travel to Trenton (from Belleville) to get my drink.   
 
I have some past problems with Shoppers Drug Mart so I have to go to 
PharmaPlus to get my drink. 
 
Kathy shared her challenges regarding access to services with this response: 
 
When I was at the other clinic I found it really, really hard.  You had to pay a fax 
fee and we‟re addicts.  Like, we don‟t have money and being on ODSP and being 
on welfare we don‟t have 10 dollars or 20 dollars to pay for a fax or if we are late 
we gotta pay 20 dollars and if you don‟t have that you don‟t get your drink.  
That‟s how I got kicked off the program up there.  If you are late for your 
appointment you get kicked off the program and you‟re done.  You don‟t get your 
drink until you get another appointment and that could be a week or two weeks so 
anyway, yeah, that‟s why I got kicked off that program up there.   
 
Even if you are like 10 minutes late getting there, you don‟t get to go in.  That‟s at 
the other one.  But down here (OATC) I find it a lot better in that aspect.  I‟m 
never late or anything like that.  I make sure that I‟m there. 
 
Kathy was asked why she thought she was asked to pay for services.  She responded: 
 
I don‟t know.  You tell me and we‟ll both know.  They penalized me.  The bill 
was like 50 dollars for faxes and me being late, like late appointments, and I don‟t 
have 50 dollars and that was it.  I said, “So what, I gotta go be a junkie again?” 
and she said, “I don‟t care what you do.  Be what you wanna‟ be.  That‟s not my 
problem.”  
 
In addition to keeping scheduled appointments, Kathy‟s challenges regarding access also  
 
involved other health issues. 
 
I‟m HIV positive and I find it really hard to get up in the morning and get going.  
Sometimes my health makes me not want to get up and out of bed.  I don‟t even 
want to move „cause I‟m in pain.  So that‟s why I‟m prescribed morphine and 
methadone.  Days where I‟m in pain.  Know what I mean? 
  
As well, Jim stated: 
I think a lot of it in the beginning with the methadone too is being able to set time 
aside to go and get your drink.  I mean, when you‟re an addict the first thing that 




Rachel provided the following information about her experience with access to MMT 
services: 
 
Well.... I gotta‟ go all the way up to the f**n pharmacy.  Excuse my language.  
Just cause.  I don‟t know why. 
 
Rachel was not feeling well the day she participated in the focus group sessions.  
Her input was sporadic and she was in and out of the room quite a bit.  I probed the issues 
related to access further.  Our brief conversation was as follows: 
Rachel: 
 




Has it always been like that though?  Just once a week and then up to the 












Yeah.  They‟re ignorant.  They tell you what to do.  They‟re not friendly.  You 
know that.  The one nurse is a brat.  I got in a fist fight one time with Dr. Pierce.  
He put me on a form 3. 
 
 Considerable evidence exists to support the inclusion of counselling to increase 
adherence with treatment protocols and retention in programs for patients receiving 
MMT (Gossop, Stewart, and Marsden, 2006; CPSO, 2005; RNAO, 2009).  In fact, the 
Methadone Maintenance Guidelines (CPSO, 2005) clearly recommend regular 
counselling as an “integral part of methadone maintenance treatment” (p. 29).  
Furthermore, the document identifies the likelihood of concurrent disorders among MMT 
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patients and suggests physicians create a judgment-fee, interdisciplinary environment in 
order to best serve their needs; thereby encouraging success with treatment strategies.  
All focus group participants were asked if they had ever received counselling or been 
referred to counselling as part of their MMT program.  Jim indicated that he has been on 
methadone for seven or eight years, Kathy for seven years, and Rachel for 15 years.  
Participants answered queries about counselling in the follow ways.  For example Jim 
stated: 
No.  And the reason for that is that the doctor that‟s at the methadone clinic here 
is also the one from jail so we have more of a jail relationship and I never had any 
kind of recommendation for counselling from any of them.  I just get my dose 
checked, get my drink, and that‟s it. 
 
Kathy: 
The only problem I had was that I had to go get blood work done and if I didn‟t 
go get that blood work done I would have got cut off methadone.  Now they‟re 
threatening me again cause I went and got my blood work done but they haven‟t 
got the paperwork yet.  That‟s the only referral I‟ve had; for blood work. 
 
Rachel‟s response was simply:  No. 
 
Methadone is consumed orally by a patient.  Dispensation of methadone 
prescribed for opiate withdrawal is highly controlled for many reasons.  Patients with 
substance abuse problems need to be regularly monitored, especially in their early stages 
of treatment, to establish dosage, and to ensure no other illicit substances are being used 
concurrently (CPSO, 2011).  Also, methadone has a value on the street.  Many patients 
live with limited or fixed incomes and, as such, may be tempted to sell their methadone to 
supplement their income.  Furthermore, as methadone is flavoured with a fruit juice, 
concern for accidental poisoning of young children is valid.  Instances of youngsters 
dying from ingesting methadone carries have been reported (Government of British 
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Columbia, 2010; Moharib, 2009)  Doctors may choose to allow patients who have been 
evaluated as medically and emotionally stabilized to take home several doses of 
methadone.  These doses are referred to as „carries‟. Patients who receive carries have 
fewer barriers related to access to MMT and are shown to have better treatment outcomes 
than those who are required to receive their medicine at a clinic or pharmacy seven days 
per week (CPSO, 2011).  Inquiry into experiences with carries during the focus group 
sessions revealed the following. 
Jim explained his experience with carries this way: 
I did (have access to carries).  Not now, I don‟t.  I was at level four.  I had four 
carries a week.  And now I have to start all over again.   
  
You have to be clean for so long and your urine samples have to be clean every 
week that you go in.  I was able to progress to four carries a week so, but like I 
said, after I had a ... I have to start all over again and start from no carries. 
 
You set your day for how you want to do it. If you have your drink you don‟t 
have to wait for the clinic to open to get your drink.  If you have your carry, as 
soon as you get up you can take your drink and start your day.  Whereas if you 
don‟t have your carry, it doesn‟t matter who you are, you still hurt and your main 
focus is gettin‟ your carry.  It doesn‟t matter who you are, what your milligram is, 
it‟s the first thing you think about having to get because your body is sore.  It‟s 
saying, “Get me your drink.” 
 
Kathy‟s experience with carries was quite different than Jim‟s.  She has never 
been granted carries although she has been accessing MMT services for seven years.  She 
shared her experiences this way when I asked her if she had ever had access to carries: 
Are you crazy?  What‟s a carry (ha ha)?  So what if I‟m suckin‟ on a pipe (crack)!  
That‟s none of your business (to Jim) or anybody else‟s God damn business.  
They ain‟t opiates and I don‟t do needles anymore.  That is what they‟re lookin‟ at 
and I‟m not on methadone „cause I‟m using crack.   I‟m on it „cause I‟m a junkie. 
  
No I have not (had access to carries).  Unless they were someone else‟s carries.  




...yeah.  „Cause then I wouldn‟t have to get up and go, you know what I mean, 
and I would be able to relax at home and whatever and walk my dogs and do 
whatever I want to do and be normal.  You know what I mean?  Instead of having 
think, okay, worry about gettin‟ up there. 
  
With my illness (HIV) there are days when I don‟t want to get out of bed.  (On 
weekends) I have to get down there by 11:00, by quarter to 1l. 
 
Similar to Jim and Kathy, Rachel has been on MMT for a very long time (15 
years).  Her response to this inquiry was similar to Kathy.  She has never been granted 
carries.  When asked if she thought carries were a good idea, her response was: 
Sometimes.  Like people have died from them. Kids die from them.  Tastes like 
orange juice. 
 
One respondent, Jeff, was never involved in a methadone program.  However, 
when the group was asked who had tried methadone in the past, Jeff indicated that he 
had.  His experience was related to acquiring methadone illegally and using it without a 
prescription.  This acquisition is referred to as methadone diversion (CPSO, 2011).  Jeff‟s 
story is important as it provides some insight into an element of methadone use which is 
of great concern.  In 2005, the College of Physicians and Surgeons of Ontario (CPSO) 
reported that there were 194 fatalities related to methadone consumption in Ontario 
between 1996 and 2000.  Of these, 154 were directly attributed to individuals consuming 
diverted methadone (CPSO, 2005).  Jeff shared his experiences with diverted methadone. 
I got it given to me by a friend.  It was a trade.  He traded me 2 – 15 ml bottles for 
40 pieces of crack.  And I was sick for three days.  I only did 30 ml and I was 
sicker than a dog.  I would never wish it on my worst enemies.   
 
There are so many people who are double-doctorin‟ that stuff too, right.  I mean, 
they get their drink and then they‟re doin‟ that same shit that they do every other 
time. They‟ll go out and get a pill or they‟ll go out and do whatever.  They still do 
it.  So I don‟t think it‟s being monitored as well as they think it is.   
 
You know, they do their drink and it‟s not enough and they‟re saying that you can 
be cut off like that (snaps his fingers) like that! (Snaps his fingers again)  You pee 
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dirty and you are done!  Boom!  There are people who have to have their drink 
„cause I‟ve seen some pretty sick people.  I‟ve seen him (my friend) get his 
methadone drink and he‟ll do four morphine pills right after it.  I‟m not kiddin‟ 
ya‟.  This guy does, he‟ll do 4 – 200 mg morphines... 
 
What changes would you like to see made to MMT programs available in your  
 
community?  Kathy responded by stating: 
 
….and what I would really like to see changed is the waiting period.  I‟m an 
addict.  I want help now not frickin‟ two weeks from now.  I want help today.  
You know what I mean?  In two weeks from now I could have a bottle of pills 
(street drugs) and be ok.  It‟s just weird.  It boggles my mind.  You know what I 
mean?  I mean, I‟m sick today.  I need help today, not two weeks from now when 
I could be in a different mind frame but it just doesn‟t work like that. 
 
Long-term drug users are extremely knowledgeable about specific dosages for 
certain drugs and what dosage will provide them with what they require (Key Informant 
Interview, 2011).  For example, Kathy has described herself as drug user who knows how 
much of which type of drug she would require to stave off dope sickness (withdrawal) or 
get high.  She feels strongly about tailoring methadone dosage to individuals and 
expressed her concerns this way: 
Kathy: 
  
Another thing I just thought of too (recommendations for improving services).  
They only leave you go to 120 (mg).  Like me, I‟m sorry, I‟m an old junkie.  Like 
excuse the expression.  Some of us need more than others!  Like, I‟m not gonna 
be rude.  Well, take it the way you want but, like, I would intravenously inject.  I 
was injecting 4 – 200 mg of morphine in one shot.  That‟s a lot.  And then you go 
down here you know.  And they say, well you can only have 120 (mg)… you 
know that‟s not doing me anything.  Like, it‟s keeping me from being sick till 
three or four in the morning.  I‟m suffering until I get down there to get my drink. 
 
Kathy was asked to confirm that her current dose of methadone is120 mg of 
methadone and that this is the highest amount she would be prescribed.  She responded: 
120 mg.  That is what I‟m on now.  Yup.  That‟s it.  That‟s it.  And then, on top of 
that, I gotta‟ have an EKG heart thing, and if I don‟t make that appointment, I‟m 




 As previously mentioned, MMT is the gold standard for managing opiate 
addiction worldwide because: 1) it is cost effective, 2) it has few side effects, 3) it can be 
taken for years if necessary, and 4) when prescribed and used appropriately, it has been 
shown to reduce harms and improve quality of life (MOHLTC, 2007).  It was important 
to ask participants about the positive side of MMT and what they thought it offered 
opiate users in Belleville, Ontario. Their responses to this question were as follows: 
Kathy responded to the query first by stating: 
I‟m not sick.  I know I‟m not gonna be sick and that‟s it for me.  The scariest 
thing I‟ve had to go through in life man.  One of the scariest.  And I don‟t know.   
It‟s excruciating...you just don‟t know.  If I had a gun, sometimes when I was 
sick, I would‟ve blown my brains out and I‟m not kidding.  Like, that‟s how harsh 
it is.  I don‟t know what you found. 
 
Jim added to Kathy‟s comments: 
 
I‟m not doing crime, breaking laws, doing whatever to make money to get... I‟m 
not in jail because of my crimes.  Doin‟ whatever I had to do to make sure I had a 
pill to make sure I had money to buy dope.  For one, I‟m not sick all the time and 
I‟m not using intravenously anymore.  So that‟s two things. 
 
Kathy agreed with Jim: 
 
 Yeah... we‟re not stealing and doing whatever to make money to get our pills.  
 
Jim stated further that: 
 
Methadone is a good program if that‟s what you want.  If you want to make 
yourself clean and keep yourself out of the criminal life.  You can still be on 
methadone and still be part of criminal part of society.  But, at the same time, if 
you‟re on methadone, it helps you stay clear there „cause you don‟t have to be out 
looking for illegal substances to make you not sick. 
 
Don‟t have to pay for it.  Like, if you‟re on any kind of Government assistance the 
Government pays for medications.  So you don‟t have to worry about getting 




Jim raises a very good point.  As long as MMT patients are receiving government 
social assistance, their drug costs (including MMT) are covered.  However, Kathy 
responded to this statement with her own personal experiences and challenges related to 
being reliant on government assistance and what could happen if MMT clients fail to 
navigate the system appropriately.  
...but if you‟re like me...  If you don‟t have your drug card...  Like me, I don‟t 
have a drug card.  I haven‟t gotten my cheque yet.  So, thank God I went up to 
disability and got my friggin‟ drug card dispensed to me anyway or I would‟ve 
been screwed.  I wouldn‟t have had a drink.  Like, if you don‟t have six dollars, 
you ain‟t gettin‟ your drink!  There‟s no compassion there either.  You don‟t have 
your drug card, you don‟t have six bucks, you don‟t get your drink. 
 
Given the earlier testament provided regarding dope sickness (withdrawal) and an 
opiate user‟s need for their medication, questions arise around what options might be 
available to MMT clients who for whatever reason, are unable to meet requirements to 
obtain their drink. 
Participants who currently access MMT in Belleville were asked if they would 
recommend a MMT program to an opiate user.   All of the participants strongly agreed 
that they would encourage someone who was addicted to prescription opiates or heroin to 
try methadone.  The focus group sessions closed with a final invitation to participants to 
express any additional thoughts, suggestions, and experiences with methadone.  Jim‟s 
response to this request provides a poignant closure to this section of the thesis: 
I cleaned myself up.  It‟s (methadone) what helped me stay clean.  It‟s what keeps 
my life going.  I mean, like I said, I was getting four carries a week.  In a lot of 
aspects I was only out on the street maybe two days a week.  The rest I‟d be in jail 
and its good cause I don‟t have to chase whatever money I can get cause I gotta 
have dope.   
 
My main concern is more compassion from the staff and more reasonability of 
them.  I know we‟re responsible for our actions but at the same time, there has to 
be some lee way by the staff as well.  Everybody makes mistakes.  You just can‟t 
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have... you shouldn‟t always be punished for your mistakes if they‟re not great big 
mistakes.  I don‟t know how else to put it. 
 
You shouldn‟t be punished for everything you did in life „cause some things 
aren‟t big enough to warrant that punishment. 
 
Key Informant Interviews 
 
 Community-based research considers the many sides and perspectives of an issue 
as presented by those most affected.  For this study, these perspectives were gathered 
during scheduled interviews with key informants.  These individuals represented a wide 
range of knowledge/experiences with MMT services in the community. Through the 
taking of field notes during visitations to the drop-in support centre, and engaging in 
conversations with downtown business owners and community members, it became 
apparent early on in the study that including the perspectives and attitudes of these 
individuals on the subject of MMT, what it was, who it served, why it was/was not 
important to the community was vital.  The key informants were identified by the 
researcher during the informal conversations and observations that took place over a 
period of five months.  As previously stated in Chapter 3, key informants were 
approached in person or by telephone and invited to participate in an informal interview 
regarding MMT services offered in their community.  All but one accepted the invitation.  
All conversations took place in a neutral, relaxed, environment mutually agreed upon by 
both parties.  Confidentiality agreements were signed, and guiding questions were used to 
prompt the conversation (see Appendix L).  No interviews were recorded.  Rather, the 
researcher took detailed field notes and confirmed accuracy of the interpretation of the 
information throughout the interviews.   
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Without this data, it would have been difficult to place the issue of MMT services 
in the context of a smaller Ontario city.  For example, some comments were made 
regarding the number of individuals who were noticed entering the downtown methadone 
clinic who were not from the area.  Would this be an issue in a larger centre, such as 
Toronto or Montreal?  Would the local business owners and community members be able 
to determine whether or not persons entering a clinic were from their city or not?  These 
types of comments underline how visible MMT clients are and raise questions about 
anonymity and stigma.  
All of the respondents identified MMT as an important health service.  However, 
questions were raised about whether or not the current for-profit model is in the best 
interest of MMT clients, the health care system, and the community.  Concerns were 
raised regarding the current monitoring of methadone clinics practices and doctor 
prescriptions for opiates such as oxycontin.  Suggestions for improving the current 
system included better monitoring and accountability for the methadone clinics and 
establishing a standardized electronic monitoring system to track opiate prescriptions and 
reduce fraudulent prescriptions. Table 11 represents the common responses gleaned from 





Table 11.  Guiding Questions and Common Responses by Key Informants 
Questions Common Responses by Key Informants 
Do you believe MMT is 
an important community 
health service? 
All individuals answered, „Yes‟ to this question. 
 
One health care individual used the word „vital‟ to describe how important this 
service is to individuals and communities. 
 
Yes, if offered in a different setting – part of a public health care centre, clinic, or 
hospital. 
What are your opinions 
about methadone and what 
it is used for? 
Methadone treatment, when it is delivered well, allows people to stop using 
(drugs) and work toward improving their quality of life. 
Opiate users have few options available if they want to stop using drugs: cold 
turkey, wean themselves off, seek medical help (MMT) 
How well do you think 
current local MMT is 
working? 
Poorly Administered.  Falls far below the best practices. 
 
Not working as well as it should.  Necessary but lacking in complete care for 
clients – only provide methadone, period. Clients are supposed to get counselling 
for addiction and other issues but that‟s not happening. 
 
Does not appear to be any incentive to get clients off of methadone.  There needs 
to be more monitoring and regulation of the clinics in the community. 
It works for the clinics more than it does for the clients. 
 
What recommendations 
would you make to 
improve local MMT 
services? 
Introduce not-for-profit clinics focused on holistic health care versus money.   
Improve access to care (transportation) and delivery of care (more time with 
physicians and referrals to other health care services). 
Ensure that methadone clinics are following Best Practices for delivering MMT – 
all clients meet criteria for receiving MMT as defined by the CPSO and clients 
receive more access to counselling for addiction and other issues 
Offer not-for-profit, Ministry funded methadone clinics through the LHINS as part 
of a Community Health Centre (CHC) 
There needs to be better monitoring/more regulation to stop people from selling 
their carries and have more emphasis on getting people off of methadone 
Improve clinic hours to allow MMT clients to access employment 
Eliminate unnecessary testing for Hep C.   
Ensure a level of care for those who test positive for HIV/Hep C 
Ensure concurrent disorders are being addressed (in-house or referral) 
 
Offer MMT in a medical arts building to reduce stigma 
 
Introduce a new electronic monitoring system to monitor prescriptions and reduce 
double-doctoring for opiates/methadone 
 
Additional Comments Keep the clinic in the downtown core but move it away from the main street 
Would be better as part of a hospital or other medical clinic 
MMT clients made their decisions on how to live and have to deal with the 
consequences 
 
Community has a lot of fear re: the downtown core and associate this with the 
methadone clinic 
People using the clinic who are not from Belleville 






 Despite the small sample size, the focus group sessions provided rich perspectives 
on all aspects of MMT services available to opiate users in a small Ontario city.  
Although some participants were not MMT clients, their experiences and perspectives on 
methadone use outside of the legal realm were insightful and important for a more 
meaningful result.  All of the concerns and observations expressed by the participants 
parallel those found in larger studies with some exceptions; notably transportation and 
clinic protocols and procedures.  The key informant interviews provided insight into the 
opinions, attitudes, and perceptions about methadone and MMT services among health 
providers, community members and MMT clients.   
The following discussion will summarize the research findings, highlight 
concerns regarding services available in smaller cities, and provide suggestions for 
















 This study attempted to understand the experiences and satisfaction with 
methadone maintenance treatment (MMT) services among opiate users residing in a 
small city in Ontario, Canada.  The quantitative results of this study highlighted several 
demographic factors associated with opiate users in the city.  For example, only 15 
(27.8%) of the 53 respondents were female and the vast majority of 45 (84.9%) were 
Caucasian.  An annual income below $19,000 was a common denominator that applied to 
47 (88.7%) of respondents who participated in the survey.  Poverty and low socio-
economic status are often associated with drug addiction (Registered Nurses Association 
of Ontario (RNAO), 2009); a statement that is also supported by this study.   
More than half of the respondents (n = 28, 52.8%) were currently accessing MMT 
for opiate dependence at the time of the study.  This means that there were 25 (47.2%) 
individuals who could have benefited from this local service but had never accessed the 
MMT programs available to them.  The question then, becomes, “Why not?”  If MMT is 
an effective medical treatment option available to these individuals, what is preventing 
them from taking advantage of these services?  The answers to this important question 
are very complex.  For example, some answers lie in the attitudes and perceptions among 
opiate users and community members in general regarding methadone, methadone clinics 
and what this type of drug and the drug treatment can or cannot do for an individual.  
Through key informant interviews, conversations with opiate users, and observations a 
lack of empathy, understanding, and fear surrounding methadone and opiate users by 
health providers and the general public was very apparent.  These negative attitudes 
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surely affect how individuals who access MMT are treated by health workers and the 
public, and are also shown to influence the decision by non-MMT users to decline 
treatment (Simmonds & Coomber, 2009).  Furthermore, the perception that local 
methadone clinics are more concerned with increasing revenues than providing care 
beyond a daily dose of methadone was prevalent among opiate users and key informants.  
Interviews with local business owners revealed the same ideas and perceptions about the 
local MMT clinics.  Key informants also expressed a level of unease regarding the central 
location of the methadone clinic and the groups of people that gather each morning to 
wait for the clinic to open.  Specifically, local business owners expressed their concerns 
for negative effects on the level of their business, property values, and the health of the 
downtown community as a whole.  Community members expressed concerns about a 
clinic interfering with attempts to improve the image and beautification of the small 
downtown core.   
On the other side of this issue are the MMT clients who are exposed and 
vulnerable while waiting for the clinic to open; well-aware of the stigma associated with 
their entering the facility.  For example, several opiate users expressed their hesitation to 
enter into a MMT program for fear of being seen entering the clinic by someone they 
know.  Some research has been conducted in Canada on the stigma associated with being 
part of a MMT program.  Information gathered parallels results from this study in that 
MMT clients expressed feeling exposed and vulnerable in smaller areas where the 
chances of encountering individuals they know while entering a MMT facility are high 
(Anstice, Strike & Brands, 2009).   
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It is also important to consider the frontline health workers who interact with 
MMT clients on a regular basis.  Providing care to patients who present with complex 
health issues can be challenging.  The likelihood of negative interactions between 
frontline health workers and clients exists and is reported in the literature (RNAO, 2009; 
Anstice, Strike & Brands, 2009; Simmonds & Coomber, 2009).  Lack of patience, 
tolerance, and compassion may be due to burn-out on the part of frontline health care 
workers.  Some common concerns that were raised during focus group sessions and open-
ended survey questions centred around interactions between frontline MMT workers, 
mostly nurses, and MMT clients.  For example, 17 (60.7%) of the participants identified 
friendlier nursing staff as a key consideration for improving MMT services at the clinic 
they attend. 
The Opinions About Methadone (OAM5) Scale used in this research confirmed 
that negative attitudes and opinions by non-MMT opiate users impacts their decision 
about whether to enter treatment.  The public‟s perception of what methadone is and what 
it is used for appeared to be largely based on fear of the criminal element often associated 
with drug addiction in general.  Furthermore, there is a perception that methadone clinics 
provide drugs to patients that get them high.  These perceptions perpetuate the stigma 
faced by MMT clients (Simmonds & Coomber, 2009).  What community members may 
fail to appreciate is that by entering into a MMT program, opiate users are taking 
important steps toward moving past a life pre-occupied with obtaining their next fix to 
avoid dope-sickness.  Individuals who choose MMT over illicit opiate use are no longer 
required to find ways to obtain enough money to support their drug habits.  This 
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translates into a reduction in petty crimes associated with illicit drug use (CSPO, 2011; 
MOHLTC, 2007).   
On more than one occasion, members of the community exhibited a lack of 
understanding for addicts; over-simplifying their plight as being the direct result of bad 
choices made by individuals who must face the consequences of their actions.  Moral 
judgement toward addicts often replaces the ability to see addiction as a complex 
physical/mental/social health issue (RNAO, 2009).  Opiate users in smaller communities 
may deal with higher levels of stigma as opposed to larger, more anonymous locales.  
Situations where MMT clients are highly visible entering or leaving facilities that 
dispense methadone contributes to the level of stigma associated with being an opiate 
user and MMT client (Anstice, Strike & Brands, 2009).  In addition to stigmatization by 
the general community, opiate users and MMT clients may also face intolerance by 
frontline health care providers (Anstice, Strike & Brands, 2009).   Expressions of 
instances involving one, or both, of these situations were common among individuals 
who participated in this research study.  Personal accounts of the same were also 
presented in a study of four methadone programs in Ontario, Canada (Anstice, Strike & 
Brands, 2009).  To be fair, blanket assumptions and statements regarding the extent of 
stigma MMT clients face should not be applied to all MMT facilities and frontline 
workers who interact with clients.  However, this issue surfaced often enough over the 
course of this study, as well as in the literature, to recommend investigation in order to 
identify the extent of discrimination and its effect on access to care and the level of care 
available to opiate users and MMT clients.  In addition, studies focused specifically on 
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smaller locales would provide the means to compare current data on larger centers in 
order to identify any key differences that may exist between the two. 
Being enrolled in MMT should allow individuals to begin a process of healing 
and provide them with supports geared to assist them to enter a life which may eventually 
be drug-free (CPSO, 2011).  When asked to rate their levels of satisfaction, 17 (60.7%) 
respondents were dissatisfied with the current MMT services they were receiving.  This 
may be related to the fact that 14 (50%) of the MMT respondents indicated they had 
never received counselling of any kind as part of their MMT program.  Counselling is not 
only recommended by the CPSO as a vital component of MMT, but specific standards 
and guidelines are provided on how to offer this component of care, when to provide it 
and why counselling should be provided.   
Access to carries (take-home doses of methadone) is another element of MMT 
programs identified by the CPSO (2011) as an important factor in retention and overall 
success.  This is a controversial topic considering the potential for accidental overdose 
and fatal outcomes associated with diverted methadone.  For this study, 21 (75%), of the 
28 MMT clients received carries after only weeks on methadone while 4 (14.3%) never 
received this option.  The CPSO (2011) recommends that MMT clients who are deemed 
medically/mentally stable be considered for receiving carries after eight weeks of 
monitored MMT.   MMT patients are also required to show proper storage (locked box) 
precautions for the potentially lethal drug are in place. The CPSO (2011) also states that 
MMT programs with overly-restrictive take-home policies have lower rates of client 
retention.  It would be worthwhile to understand if these statements are generalizable 
across the province, regardless of the size and location of a community.    
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There is considerable evidence showing a significant increase in prescription 
opiates over the past decade (Fischer, Gittins & Rehm, 2008).  More importantly, the 
illegal use of prescription opiates by younger individuals who have never used heroin is 
on the rise in smaller centres (Fischer, Gittins & Rehm, 2008).  Information collected for 
this study supports these findings.  Several potential survey participants had to be 
excluded from the study because they were younger than 18 years.  All potential 
respondents were briefly interviewed prior to completing a survey in order to verify their 
age and level of opiate use.  If not for their age, many young adults would have qualified 
for the study.  All indicated they were using prescription opiates exclusively.  Also, 26 
(49%) of survey respondents indicated using prescription opiates on a regular basis as 
opposed to just 7 (13.2%) who used heroin.  Current MMT programs and services were 
originally designed to manage addiction to illicit opiates (heroin).  There is not enough 
evidence to definitively state that these current treatments are the best/only option for this 
new trend in opiate use (CPSO, 2011).   
Study Limitations 
 
True community-based research (CBR) is subject to limitations by its very nature.  
Specifically, working with marginalized populations over a vast geographical area 
impacts the access to research subjects.  For this study, access to the target population 
was not always guaranteed due to health issues, time management issues, and mental 
illness associated with drug addiction.  As well, potential subjects may have known about 
the opportunity to participate in the study but did not have the transportation available on 
the days when the surveys and/or focus group sessions were offered.  The drop-in centre 
received phone calls from individuals interested in participating in the study but who 
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were unable to secure transportation into Belleville on the days when the study was 
taking place. 
The willingness of subjects to disclose personal information to persons they do 
not know or trust (including researchers) may be limited or non-existent.  Trust is a 
relationship that is developed over time.  As such, data collection associated with CBR 
studies may need to take place over longer periods of time.  Networking with various 
community groups that support and service the target population may also prove 
challenging.  
Due to the socio-economic status of the target population, potential research 
subjects may be more interested in the monetary incentives versus the research itself.  As 
such, individuals may provide fraudulent information in order to receive money 
associated with participation in a study.  This was observed once regarding completion of 
the survey and three times during the course of the focus group sessions.  
Opinions and responses provided by respondents may be based on poor 
information and/or lack of education regarding the topic.  For example, this was observed 
among non-MMT opiate users that completed the OAM-5 Scale, community 
stakeholders, and key informants.  Inaccurate ideas, perceptions, and assumptions about 
methadone and MMT were prevalent and largely influenced how MMT clients were 
viewed and treated by frontline health workers and the general community. 
This research was, in many ways, a starting point.  It is difficult to know which 
questions to ask until without having spent time with the target population and observed 
them in their day to day lives.  Similarly, it is difficult to know if public opinion is based 
on correct information.  Spending time and speaking with members of the community 
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and health workers was necessary to determine their knowledge about methadone and 
MMT.  It is only after spending time that suggestions for improving the level of 
understanding among community members and caregivers can be put forward. 
One study is not sufficient for answering all of the questions that need to be 
answered.  In fact, this study generated more questions than it answered.  Gathering 
qualitative data is particularly challenging with CBR – especially CBR focused on 
marginalized populations.  This study barely scratched the surface of the qualitative 
inquiry necessary to fully understand how current services, or lack thereof, impact the 
individuals who require them.  Field notes and observations gathered during the course of 
this study strongly suggest more qualitative inquiry would be a vital component for any 
future studies in order to truly understand how to best serve the target population. 
Recommendations and Future Studies 
 
Future studies focused on ways to improve current MMT services and increase 
retention rates in smaller locales are warranted.  The development of initiatives and 
strategies to care for individuals who require assistance with their prescription opiate 
dependence is also needed.  Monitoring systems and policies are also needed across the 
province, and the country, to address the influx of prescription opiates into the illicit drug 
market before the associated health care and societal costs sky-rocket out of control.  
Investigation into the availability of ongoing support and relief for frontline staff may 
provide insight into how to maintain a more positive treatment environment for health 
providers and MMT clients.  In addition to ensuring MMT best practices (provision of 
counselling and other social supports) are employed throughout the province, research 
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into exploring alternative treatment strategies and substitute therapies for opiate 
dependence, including prescription opiates, may be helpful.   
Alternative treatments, such as Supervised Injection Facilities (SIF) have been 
shown to reduce crime rates, to improve injection practices which reduce harms to users 
and communities, and to reduce the number of emergency room visits for soft tissue 
trauma related to injection practices (Firestone-Cruz et al, 2007).  The success of these 
controversial approaches is largely dependent on public opinion.  For example, the 
perception by the general public that SIFs encourage drug use has been empirically 
proven to be false.  However, the belief that SIFs invite this type of behaviour largely 
determines whether or not community leaders and policy makers present it as a viable 
option (Firestone-Cruz et al, 2007).  This begs the question, „with the increased 
prescription opiate use, would similar facilities to monitor these opiate users be viable?‟  
Ongoing monitoring by organizations such as the CPSO and/or non-governmental 
agencies should be implemented to ensure accountability for any lack of provision of key 
services, including counselling and social supports for clients.   Furthermore, the CPSO 
must be diligent in the enforcement of MMT standards and guidelines on behalf of MMT 
clients in the province of Ontario.  MMT clients may not feel free to express their 
dissatisfaction with treatment by staff and the quality of care they receive for fear of 
being involuntarily withdrawn from a MMT program.  This point was communicated 
repeatedly by MMT clients throughout the course of this research study.  It would be 
important to compare the quality of care between large cities and smaller locales and 








Drug addiction is a medical/social condition with a long human history.  As such, 
it is crucial for ongoing initiatives and strategies to assist individuals struggling with this 
complex, evolving issue.  Input from community stakeholders, policy makers, and opiate 
users is crucial for success.  Given the notable increase in dependence on prescription 
opiates, this study is timely.  The results will not only benefit current treatment practices 
but may provide additional support for challenges specific to those programs operating in 
smaller locales including:  access to care, quality of care, and stigma.   
This study examined the current experiences and satisfaction with MMT services 
available to opiate users in a small Ontario city.  Although the survey data provided 
important information regarding the characteristics and demographics of the sample 
population, without the qualitative component, this study would have been unable to 
accurately depict the circumstances surrounding the broader issues.  Further qualitative 
inquiry to explore how opiate users‟ lives are affected by current MMT systems in 
smaller locales would be most beneficial in developing health care policies and treatment 
strategies for this very vulnerable population.  Finally, based on the current trends in 
opiate use, studies are needed to gather statistical data regarding the number of 
individuals who are dependent on prescription opiates in small towns, how they access 
the drugs, and whether or not current MMT services are sufficient to deal with the 
problem.   
Engaging in conversations with community members and conducting key 
informant interviews regarding their perceptions and opinions about having two 
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methadone clinics in the community provided a most interesting perspective.  All key 
informants expressed similar positive views about the importance of having MMT 
services available in the community.  Their opinions about the negative aspects were also 
unanimous.  All interviewees expressed their concerns about the local clinics not being 
associated with a not for profit community health service.  Specifically, the local hospital, 
health unit or other community-based health center were suggested as being more 
appropriate locations for MMT services. There was no discussion about removing the 
clinics altogether.  Rather, this dialogue was centred on moving the existing downtown 
clinic to a less visible area of the city and whether or not the addition of a not-for-profit 
clinic in the community would be possible.  These sentiments were also expressed by 
MMT clients who identified the clinic‟s location as a barrier to care on several occasions. 
It was very encouraging to hear all interested parties express their support for the 
presence of MMT services in the community.  The only real questions raised about the 
local methadone clinics were around the quality of service being provided in a for-profit 
setting, and the location of the downtown clinic.  Where the unanimous opinions ended 
was in regard to the individuals who receive methadone at the local clinics.  It was very 
clear that the community members and business owners did not have a good 
understanding of the complexity of addiction.  The lack of knowledge around addiction 
and how MMT works to assist those who are opiate dependent translated into a lack of 
compassion for MMT clients and their circumstances.  
The next step toward improving care for this marginalized population may be to 
provide better information to communities where MMT services are available, and 
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encourage dialogue among all interested parties:  health providers, clients, and 
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Thank you for participating in the following questionnaire.  There may be some 
questions you do not feel comfortable answering.  Please answer only those questions 
you want to.    
 









2. How old are you?  
 Under 19 
 19 – 29  
 30 – 39  
 40 – 49  
 50 +  
 
3. Many people identify with a specific ethnic or racial category.  What is your racial 
or ethnic identification? 
 Aboriginal/ Native Canadian 
 Asian 
 Black 
 Mixed (specify e.g. Asian/Aboriginal) ____________________________ 
 White  
 Other (specify) _________________________________ 
 
4. How would you describe your current relationship status (please check one) 
 None 
 Dating (casual relationships) 
 Current significant involvement, but don’t live together 
 Current significant involvement, living with a partner 
 
5. How many children (under the age of 19) including any adopted children or 
stepchildren do you have?_________________________(number of children) 
 






7. What is the highest level of education you completed? 
 Public school 
 High school 
 College or University 
 Other: ____________________________ 
 
8. What was your total personal income (before taxes) for the 2009 tax year 
(January 2009 – December 2009) 
 $0 - $19,000    
 $20,000 - $59,000 
 $60,000 - $99,000   
 $100,000 +    
 
9. In the last 12 months, where did you get your money from?  Please check (√) all 
that apply. 
 Regular employment 
 Occasional employment 
 Unemployment insurance 
 Social assistance/ Welfare 
 Educational grant/Scholarship 
 Illegal activities 
 Sex trade/ prostitution 
 Other (specify _____________________________________________) 
 
10. Where do you live? 
 Quinte West (Trenton)  
 Belleville  
 Picton  
 Other _______________________________ 
 
11. How would you describe your housing situation in the last 12 months? Please 
check all that apply. 
Housing Check here 
Shelter (specify ______________________)    
On the street  
Rent an apartment  
Rent a room  
Stay with friends  
Boarding house  
Own my own home  
Live with my parents  
Other (specify _______________________)   
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12. Have you been homeless in the last 30 days?  This includes couch surfing, 
sleeping outside, or sleeping at a shelter. 
 No 
 Yes  if yes, how many days out of the past 30 days were you homeless? 
___________ (number of days) 
 
The next set of questions will ask about your health and health care. 
 
13. Generally speaking, how would you rate your overall health? 
Would you say your health is 
 Excellent  





14. Where do you usually go for health care?  That is, which places do you rely on 
the most when you are sick or have a health problem?  Please check all that 
apply (√). 
 Hospital Emergency Room      
 Health Unit     
 Family and Friends     
 Family Physician    
 Walk-in Clinic 
 Pharmacist 
 Methadone clinic 
 Other (specify __________________________________) 
 
15. Do you have someone you can really count on to listen when you need to talk? 
 No 
 Yes (briefly describe relationship _____________________________) 
 
 
The next set of questions will ask you about your drug use. 
 









18. If yes, what kind of opiates do you use to get high? 
 Heroin 
 OxyContin (Including percocet/ percodan) 
 Other _______________________________________________________ 
 Does not apply 
 




 Other _______________________________________________________ 
 Does not apply 
 
20. In the past 12 months, about how often did you inject drugs? 
 Does not apply 
 Never 
 Once in a while, not every week 
 Once or twice a week 
 Three times a week or more, but not every day 
 Every day 
 
21. In the last 12 months, did you inject drugs with needles or syringes already used 
by someone else, including your partner? 
 Never 
 Once only 
 Sometimes 
 Every time 
 Does not apply 
 
22. In the last 12 months, have you ever used other injecting equipment (spoons, 
filters, water or cotton) already used by someone else, including your partner? 
 Never 
 Once only 
 Sometimes 
 Every time 
 Does not apply 
 
23. Where do you get your needles and syringes from? 
 Pharmacy with Needle Exchange Program 
 Pharmacy without Needle Exchange Program 
 Dealer 
 Friend 
 Needle exchange program (non-pharmacy site) 
 Other (specify __________________) 
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24. Has using opiates led to any of the following?  Please check as many as apply (√). 
 Financial problems 
 Relationship breakup (ie. Marital/life partner, children, other 
__________) 
 Career/employment problems (ie. Loss of employment, poor work 
performance, frequent change of job) 
 Legal problems (ie. Fines, jail term, loss of “bonding”, etc) 
 Mental health problems 
 Other (specify ____________________________________) 
 
25. What medical problem(s) do you feel you have had or have, that you feel may 
have been directly related to your use of opiates?  Please check all that apply 
(√). 




 Stomach Problems 
 Other infections 
 Other (specify ______________________) 
 
   The next set of questions will ask you about your experience with Methadone 
Treatment 
 
26. Have you ever used Methadone as part of a drug treatment program? 
 Yes  
 No  
 If no, why not? 
__________________________________________________ 
 
***If no, please go to QUESTION 39 on Page 8 to continue with the survey. 
 
27. How long have you been accessing Methadone Treatment services: 
based in Belleville?____________ months OR outside of Belleville? 
________months 
 
If outside of Belleville, where have you been going? ______________________ 
 
28. Which services are being provided to you in Belleville as part of your Methadone 
Treatment Program? 
 Counselling       Within the clinic ___     Outside the clinic ___ 
 Referral to other doctors                 
 Referral to social services                       No services were provided ___ 
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29. How many times in your lifetime have you started a Methadone Treatment 
program? 
__________ number of times    _____ never 
 
30. Do you OR did you find it difficult to stick with the Methadone Treatment 
program? 
 Yes  
 No  
 Does not apply 
 
31. How long were you in the Methadone Maintenance Treatment program before 
you were able to have “carries”? 
____  # of weeks 
____  # of months 
____ carries were never allowed 
 
 Does not apply 
 
32. How often did you have access to structured counselling as part of your 
Methadone Treatment plan? 
       ____ times per week 
 ____ times per month 
 ____ never  
 
33. Have you been referred to other counselling outside of the Methadone 
Maintenance Treatment program? 
  Addictions Counselling 
  Social Services 
  Family Counselling  
  Job Counselling 
  Other (specify __________________________________) 
  Does Not Apply 
 
34. How satisfied are you with the services you are currently receiving as part of 
your treatment at the Methadone Clinic? 
 Very Dissatisfied  
 Dissatisfied  
 Satisfied  
 Very Satisfied  






35. In the past, was it hard to stick with a Methadone Treatment program because 
of any of the following reasons? Please check all that apply (√). 
 I was ill and missed part of the program/treatment 
 There was no ongoing counselling/ support available 
 I was not ready for the program or treatment 
 The program was culturally inappropriate 
 I had no support from friends or family 
 I would lose my income by entering into a program  
 The program was full 
 The program didn’t start right away (e.g. when I was ready) 
 I had no child care 
 I had no way of getting there (bus tickets, transportation) 
 I was unable to understand the instructions 
 I didn’t want them to know I was still using drugs 
 I felt mistreated or judged negatively by the healthcare or service 
provider 
 I felt the healthcare or service provider did not respect me 
 Other: (Explain ______________________________________________) 
 
 
36. In the past 12 months, how often did you miss any of your appointments with 
physicians, nurses, counsellors or other service providers?  Please circle the 
number. 
1                             2                           3                            4                       5 
                      Never              A few times        Half the time        Many times        Always 
 
37. The following are reasons why some clients receiving Methadone Treatment 
miss their appointments with doctors, nurses, counsellors or others. Did any of 
these apply to you?   
 I forgot 
 I was too high 
 I was “on the nod” 
 I was sleeping 
 I was sleep deprived 
 I had no bus tickets or other transportation 
 I had no child care 
 I was unable to understand the healthcare/ service provider’s instructions 
 I couldn’t find the place 
 I felt mistreated/ judged negatively by healthcare/service provider in past 
 I felt the healthcare or service provider did not treat me with respect  
 I didn’t want them to know I was still using drugs 
 Other: (Explain ____________________________________________) 
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38. Please indicate all of the reasons why it is hard to stick to a Methadone program. 
 I was ill 
 I needed a program where I could continue to use other drugs 
 Other people in the program were threatening me 
 Other people in the program were using injection drugs 
 Other people in the program wanted my carries 
 Other people in the program were carrying weapons 
 I was not ready for the program 
 I had no support from friends or family 
 I would lose my income by entering into the program 
 The program didn’t start right away (e.g. when I was ready) 
 I had no child care 
 It was difficult to get to the Doctor’s for my appointments 
 It was difficult to get to the pharmacy to get my methadone 
 I couldn’t “carry” any or enough of my doses 
 I was unable to understand the instructions 
 I felt mistreated / judged negatively by the healthcare or service provider 
 I felt the healthcare or service provider did not respect me 
 I was still using 
 
The next set of questions will ask you about your access to Health Services 
 
39.  Below is a list of services available in the area.  Which ones have you used in the 
past 12 months?  Please check all that apply (√). 
  Medical care (family doctor, hospital / walk-in clinics, emergency room) 
  Mental health programs (specify __________________) 
  Needle exchange  
  Food bank 
  Detox (regional services in Kingston) 
  Methadone programs ( ___ in Belleville OR ___ outside of Belleville) 
  Addiction programs (specify ___________________) 
  Sexual health clinics (health unit) 
  Meal programs 
  Sexual assault center 
  Self-help 
  Social services (Ontario Works, Financial & Employment Counseling) 
  Local Churches 
  Other (specify ________________________) 
 
40. Have you ever been denied access to OR been “banned” from any of the services 
listed? 
 No  
 Yes  
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If yes, please choose from the following list of reasons.  Please check all that apply (√). 
 You had criminal charges pending 
 They said you were too high 
 They said you were too threatening 
 They said you were not cooperative 
 You were suspected of getting the same prescription from more than one 
doctor 
 You were suspected of re-selling your prescription once it was filled 
 They said you were not ready for a program 
 Other: (Explain ___________________________________________________ 
 
41. Availability of services is important to people. Please rate how important it is to you that 
the following services (even if not available in your area) are EASILY available to you? 
 










Safe Injection Site      
Needle Park      
 Harm Reduction 
Drug Treatment 
     
Clean Works      
Drug Treatment - -
Abstinence 
     
Medical Detox      
Aboriginal Drug 
Treatment Center 
     
Methadone 
Treatment Program 
     
Nutritious Food 
Supplies 
     
Street Outreach      
Needle Exchange      
Overnight Shelters      
Welfare/ Ontario 
Works/ ODSP 
     
Health Care Services      
HIV Testing      
Hepatitis Testing      
Hepatitis B Vaccine      
Birth Control      
Free Condoms/ 
Dental Dams 









42. What, in your opinion, could be done to improve the access to methadone in 
Hastings and Prince Edward counties?  For example:  better hours, more 







43. What could be done to improve the services available to clients at the 










44. Finally, do you have any other comments / suggestions regarding your needs, 






















45. The following are questions from the “Opinions About Methadone” 
Questionnaire.   
 
Please provide a number at the end of each question to indicate your response based on 
the following: 
1 = Strongly Disagree 
2 = Disagree 
3 = No opinion 
4 = Agree 
5 = Strongly Agree  
 
Opinions About Methadone Response 
(1 - 5) 
1. It is safe to take methadone   
 
 
2. Taking methadone is only replacing one addiction with another  
 
 
3. It is better to use no medication than to take methadone  
 
 




5. With methadone, you can eventually get off of illegal drugs 
 
 
6. Methadone has proven to be the best way of quitting opiates like 
heroin and oxycontin. 
 
 
7. Methadone helps us lead a normal life 
 
 
8. Methadone programs help decrease illegal drug problems 
 
 
9. People are afraid to taper off of methadone 
 
 
10. My friends think it’s practically impossible to get off of methadone 
 
 
11. Most people don’t understand how hard it is to get off methadone 
 
 
12. I would feel empty without methadone or another drug 
 
 
13. Methadone programs sometimes act as agents for police 
 
 




END OF QUESTIONNAIRE  
Thank you for your time and participation with this important research study.   





Sample of Guiding Questions for Focus Group Sessions 
The following represent a sample of the types of guiding questions used during the Focus 
Group Sessions: 
1. How many of you currently use opiates? 
2. How many of you currently access MMT in Belleville (either OATC or First 
Step)? 
3. How many of you are not currently accessing MMT in Belleville? 
4. How many of you have tried MMT in the past but are not currently in a program? 
5. For those of you currently accessing MMT in Belleville, what are the good things 
about the program? 
6. For those of you currently accessing MMT in Belleville, what are some things 
about the program that you would change? 
7. For those of you NOT currently accessing MMT in Belleville, why aren‟t you? 



















The University of Ontario Institute of Technology (UOIT) in 
partnership with the Hastings and Prince Edward Counties Injection 
Drug Use Harm Reduction Task Force are conducting research on 
MMT services. 
 
WE NEED YOUR INPUT  
to  
Improve Methadone Treatment Services in Your 
Area!! 
 
 We would like to gather information from individuals who might 
require Methadone Treatment and would be willing to provide us 
with information that could help improve services in your area. 
 
A survey is available at Belleville Freedom Support Center  
Every Tuesday & Thursday: 10:00 - 3:00  
from June 11, 2010 to July 31, 2010. 
 
Assistance with completion of the survey will be provided. 
 
Eligible participants will receive $20 for participating in the survey. 
Your input is very valuable! 
 








The University of Ontario Institute of Technology (UOIT) in 
partnership with the Hastings and Prince Edward Counties Injection 
Drug Use Harm Reduction Task Force are conducting research on 
MMT services. 
 
Have you participated in the survey about  
Opiate Use and Methadone Treatment Services? 
 
If you have, you are eligible to participate in one of 
two focus group sessions about the subject…. 
 
 We would like to gather information from individuals who might 
require Methadone Treatment and would be willing to provide us 
with information that could help improve services in your area. 
 
Focus Group Sessions will be held at Belleville Freedom Support 
Center  
 Session 1:  Tuesday, August 3 from 5:00 - 7:00 pm  
 Session 2:  Thursday, August 5 from 5:00 - 7:00 pm 
 
Pizza and beverages will be served and $20.00 will be paid to each 
eligible participant.   
 
Each session is limited to a maximum of 8 people so please 
reserve your spot by adding your name to the sign in sheet. 
 









Letter of Invitation 
 
Title of Project: Effectiveness of Methadone Maintenance Treatment Services 
Available to Opiate Users in Hastings and Prince Edward Counties. 
  
Introduction  
A research project to evaluate the effectiveness of methadone maintenance treatment for 
opiate users in Hastings and Prince Edward Counties, Ontario is being conducted by 
University of Ontario Institute of Technology (UOIT) MHSc student, Lorri Taylor and 
one Co-Principal Investigator, Dr. Robert Weaver, PhD, Faculty of Health Sciences at 
UOIT.  
 
The purpose of the research project is to evaluate the effectiveness of methadone 
maintenance treatment programs currently available to opiate users in Hastings and 
Prince Edward Counties, Ontario. The objective of this study is to determine if treatment 
options currently being offered to opiate users in Hastings and Prince Edward Counties 
are meeting the health care needs of persons receiving methadone maintenance treatment. 
 
You are being invited to participate in this study because you currently use opiates and 
may now, or in the future, require methadone maintenance treatment.  You are invited to 
participate in the questionnaire provided at this location if you meet the following 
requirements: 
 You are 18 years of age or older 
 You have not already completed this survey  
 You are not currently receiving methadone maintenance treatment outside of 
Hastings / Prince Edward Counties. 
 
This study has been reviewed and has received Ethics approval through the Research 
Ethics Board (REB) at UOIT (File # 09-114).  For further information regarding the REB 
process, please contact the REB Administration/Compliance Officer at: 
compliance@uoit.ca or 905-721-8668 ext. 3693.  
 
If you have any questions regarding this research study, please contact Lorri Taylor at 
613-969-1913 ext 2453. 







Letter of Informed Consent  
 
Title of Project: Effectiveness of Methadone Maintenance Treatment Services 
Available to Opiate Users in Hastings and Prince Edward Counties. 
  
A research project to evaluate the effectiveness of methadone maintenance treatment 
(MMT) for opiate users in Hastings and Prince Edward Counties is being conducted by 
University of Ontario Institute of Technology (UOIT) MHSc (candidate), Lorri Taylor 
and one Co-Principal Investigator, Dr. Robert Weaver, PhD, Faculty of Health Sciences 
at UOIT.   
 
This study has received Ethics approval through the Research Ethics Board (REB) at 
UOIT (File # 09-114).  For further information regarding the REB process, please contact 
the REB Administration/Compliance Officer at: compliance@uoit.ca or 905-721-8668 
ext. 3693. 
 
Participation in this study involves 25 minutes to complete a survey about your 
experience with MMT and current health services you receive. Your participation is 
voluntary. You may stop your participation at any time for any reason with no penalty or 
negative consequences. Your name will not appear on any form. There will be no way to 
link a participant with a survey.  All data will be locked in a cabinet in the Co-Principal 
Investigator‟s office at UOIT and only the investigators will have access. Data will be 
kept for 3 years after first publication. After 3 years, all paper associated with the project 
will be shredded.  No single individual will be referred to or identified in any written 
report. 
 
This study will provide a better understanding of the effectiveness of MMT available in 
Hastings and Prince Edward Counties.  Findings will be used to assist health providers 
and facility managers determine if current treatment practices are meeting the needs of 
the population and if additional treatment options should be considered. There are no 
known risks associated with participation in this study. 
 
The street nurse will assist you with filling out the survey. You will receive $20 for your 
time and you may stop at any time for any reason with no penalty.  If you have any 
questions about the study or would like to know the results, please contact the 
investigators. 
 
To confirm your willingness to participate in this study, please sign this consent form. 
Thank you for your time. 
 
I acknowledge by signing this consent form that I will participate in the above study. 
_______________________________         _____________________                      
      Participant Name (please print)          Date 
 
_______________________________                ______________________ 
Participant signature    Date 
The Injection Drug Use  
Harm Reduction Task Force 
Hastings & Prince Edward 
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                                  Appendix G 
 
April 15, 2010. 
 
Letter of Invitation 
 
Title of Project: Effectiveness of Methadone Maintenance Treatment Services 
Available to Opiate Users in Hastings and Prince Edward Counties. 
  
Introduction  
A research project to evaluate the effectiveness of methadone maintenance treatment for 
illicit opiate users in Hastings and Prince Edward Counties, Ontario is being conducted 
by University of Ontario Institute of Technology (UOIT) MHSc student, Lorri Taylor and 
one Co-Principal Investigator, Dr. Robert Weaver, PhD, Faculty of Health Sciences at 
UOIT.  
 
The purpose of the research project is to evaluate the effectiveness of methadone 
maintenance treatment programs currently available to opiate users in Hastings and 
Prince Edward Counties, Ontario. The objective of this study is to determine if treatment 
options currently being offered to opiate users in Hastings and Prince Edward Counties 
are meeting the health care needs of persons receiving methadone maintenance treatment. 
 
You are being invited to participate in this study because you currently use opiates and 
may now, or in the future, require methadone maintenance treatment.  This part of the 
study involves a focus group meeting where the researcher will openly ask questions to a 
group of no more than eight people.  You are invited to attend one of three focus group 
sessions being offered at Belleville Club Freedom if you meet the following 
requirements: 
 You are 18 years of age or older 
 You have not already attended one of the three focus groups  
 You are not currently receiving methadone maintenance treatment outside of 
Hastings / Prince Edward Counties. 
 
The focus groups are being offered at Belleville Club Freedom on the following dates: 
 Session 1:  August 1 at 7:00 pm  
 Session 2:  August 3 at 7:00 pm 
 
This study has been reviewed and has received Ethics approval through the Research 
Ethics Board (REB) at UOIT (File # 09-114).  For further information regarding the REB 
process, please contact the REB Administration/Compliance Officer at: 
compliance@uoit.ca or 905-721-8668 ext. 3693. 
 
Thank you very much for your participation in this research study. 
 
The Injection Drug Use  
Harm Reduction Task Force 




April 15, 2010. 
 
Letter of Informed Consent 
 
Title of Project: Effectiveness of Methadone Maintenance Treatment Services 
Available to Opiate Users in Hastings and Prince Edward Counties. 
  
A research project to evaluate the effectiveness of methadone maintenance treatment 
(MMT) for illicit opiate users in Hastings and Prince Edward Counties is being 
conducted by University of Ontario Institute of Technology (UOIT) MHSc (candidate), 
Lorri Taylor and one Co-Principal Investigator, Dr. Robert Weaver, PhD, Faculty of 
Health Sciences at UOIT.   
 
This study has received Ethics approval through the Research Ethics Board (REB) at 
UOIT (File # 09-114).  For further information regarding the REB process, please contact 
the REB Administration/Compliance Officer at: compliance@uoit.ca or 905-721-8668 
ext. 3693. 
 
Participation in this study involves your participation in a Focus Group Session about 
your experience with MMT and health services you receive. Your participation is 
voluntary. You may stop your participation at any time for any reason with no penalty or 
negative consequences. Your name will not appear on any form. The sessions will be 
audio taped and notes will be taken.  All data will be transcribed and locked in a cabinet 
in the Co-Principal Investigator‟s office at UOIT.  Only the investigators will have 
access. Data will be kept for 3 years after first publication. After 3 years, all paper 
associated with the project will be shredded. No single individual will be referred to or 
identified in any written report. 
 
This study will provide a better understanding of the effectiveness of MMT available in 
Hastings and Prince Edward Counties to assist health providers and facility managers 
determine if current treatment practices are meeting the needs of the population and if 
additional treatment options should be considered. There are no known risks associated 
with participation in this study. 
 
You will receive $20 for your participation.  You may choose to leave the focus group at 
any time with no penalty.  If you have any questions about the study or would like to 
know the results, please contact the investigators. 
 
To confirm your willingness to participate in this study, please sign this consent form. 
Thank you for your time. 
 
I acknowledge by signing this consent form that I will participate in the above study. 
      _______________________________         _____________________                      
      Participant Name (please print)          Date 
_______________________________                ______________________ 
Participant signature    Date 
 
The Injection Drug Use  
Harm Reduction Task Force 






Research Assistant Confidentiality Agreement 
 
Project title:  Effectiveness of Methadone Maintenance Treatment Services Available to 
Illicit Opiate Users in Hastings and Prince Edward Counties. 
Researcher’s Name:  Lorri Taylor 
Research Assistant’s Name:  
The questionnaire and focus group sessions you are helping to facilitate involve collection of 
information as part of a research project. This material may contain information of a very 
personal nature, which should be kept confidential and not disclosed to others. Maintaining this 
confidentiality is of utmost importance to the University, the participants, the researcher, and 
the Research Ethics Committees who have approved this research. 
I request that you agree to the following:  
 You will not disclose to others any information you may hear while facilitating 
completion of questionnaires or attending focus group sessions.   
 You will not disclose to others the identity of any participants who fill out questionnaires 
or take part in any of the focus group sessions. 
Declaration 
I understand that: 
1. I will only discuss the content of the questionnaires and focus group sessions with 
participants and the researcher. 
2. I will not disclose to others the identity of any participants who fill out questionnaires or 
take part in any of the focus group sessions. 
 
I agree to act according to the above constraints 
Your name   _________________________________ 
Signature ___________________________________ 






Focus Group Participant Confidentiality Agreement 
 
Project title:  Effectiveness of Methadone Maintenance Treatment Services Available to 
Illicit Opiate Users in Hastings and Prince Edward Counties. 
Name of Focus Group Participant: 
________________________________________________ 
The audio recording and field notes taken during this Focus Group Session have been collected 
as part of a research project. This material may contain information of a very personal nature, 
which should be kept confidential and not disclosed to others. Maintaining this confidentiality is 
of utmost importance to the University, the participants, the researcher, and the Research 
Ethics Committees who have approved this research. 
I willingly agree to the following:  
 I will not disclose to others any information I may hear during this focus group session.   




I understand that 
1. I will only discuss the content of this focus group session with the researcher, the street 
nurse and other focus group participants.  
 
I agree to act according to the above constraints 
 
Your name   _________________________________ 
Signature ___________________________________ 
Date        ____________________________________ 







Transcription Confidentiality Agreement 
Project title:  Effectiveness of Methadone Maintenance Treatment Services Available to 
Illicit Opiate Users in Hastings and Prince Edward Counties. 
 
Researcher’s Name:______________________________________________________ 
The audio recording you are transcribing has been collected as part of a research project. This material 
may contain information of a very personal nature, which should be kept confidential and not disclosed to 
others. Maintaining this confidentiality is of utmost importance to the University, the participants and the 
Research Ethics Committees who have approved this research 
I request that you agree to the following:  
 You will not disclose to others any information you may hear on the audio recording.   
 The audio recording must be kept in a secure place where it cannot be heard or viewed by other 
people. 
 Your transcription will be shown only to members of the research team. 
 If you find that anyone on the audio recording is known to you (not including the research 
assistant), you will stop the transcription or coding work immediately and contact him/her. 
 The written transcripts will be stored on a password protected computer.  
 On completion of the transcription, the audio material and all computer files/written information 
will be sent to members of the research team. You will destroy your personal copy of this 
information once the research has been completed.  
Declaration 
I understand that: 
1. I will only discuss the content of the audio recording with members of the research team.  
2. I will keep the audio recording in a secure place where it cannot be seen/ heard by others. 
3. Transcriptions will be stored on a password protected computer and only discussed them with the 
research team.   
4. If any person on the audio recording is known to me (not including the research assistant), I will stop 
the transcription or coding work immediately and contact the research team. 
5. Once the transcription work is completed I will delete/destroy copies of the transcripts/coding. 
I agree to act according to the above constraints 
 
Your name   ____________________________________ 
Signature ___________________________________ 
Date        ____________________________________                                                                                      




Letter of consent for Key Informant Interviews 
 
November 6, 2010. 
Letter of Informed Consent 
Title of Project: Effectiveness of Methadone Maintenance Treatment Services 
Available to Illicit Opiate Users in Hastings and Prince Edward Counties. 
  
A research project to evaluate the effectiveness of methadone maintenance treatment 
(MMT) for illicit opiate users in Hastings and Prince Edward Counties is being 
conducted by University of Ontario Institute of Technology (UOIT) MHSc (candidate), 
Lorri Taylor and one Co-Principal Investigator, Dr. Robert Weaver, PhD, Faculty of 
Health Sciences at UOIT.   
 
This study has received Ethics approval through the Research Ethics Board (REB) at 
UOIT (File # 09-114).  For further information regarding the REB process, please contact 
the REB Administration/Compliance Officer at: compliance@uoit.ca or 905-721-8668 
ext. 3693. 
 
Participation in this study involves your participation in a conversation about your 
experience and perspective regarding MMT services currently available in Hastings and 
Prince Edward Counties. Your participation is voluntary. You may stop your 
participation at any time for any reason with no penalty or negative consequences. Your 
name will not appear on any form. The sessions will not be audio taped however, field 
notes will be taken.  All data will be transcribed by the Principal Investigator and locked 
in a cabinet at their residence until the completion of the research study at which time the 
data will be destroyed. No single individual will be referred to or identified in any written 
report. 
 
This study will provide a better understanding of the effectiveness of MMT available in 
Hastings and Prince Edward Counties.  Information gathered will assist health providers 
and facility managers determine if current treatment practices are meeting the needs of 
the population and if additional treatment options should be considered.  Participation in 
this conversation will contribute a perspective that will help provide meaningful context 
for the study.  There are no known risks associated with participation in this study. 
 
There is no compensation for participation in this conversation.  You may choose to stop 
the conversation at any time with no penalty.  If you have any questions about the study 
or would like to know the results, please contact the investigators. 
 
To confirm your willingness to participate in this conversation, please sign this consent 
form.  Thank you for your time. 
 
I acknowledge by signing this consent form that I will participate in the above study. 
      ______________________________            _____________________                      
      Participant Name (please print)          Date 
_______________________________                ______________________ 




Sample of Guiding Questions for Key Informant Interviews 
The following represent a sample of the types of guiding questions used during the Key 
Informant Interview sessions: 
1. Do you believe methadone maintenance treatment (MMT) is an important health 
service? 
2. What are your opinions about methadone and what it is used for? 
3. How well do you think current local methadone treatment services are working? 
4. What improvements do you feel need to be made to MMT services that are 
available locally? 
5. What suggestions do you have for improving the MMT services that are available 
locally? 
6. What are some other issues related to local MMT services that you feel are 
important? 
 
